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ABSTRACT
COMPARISON OF TWO DIFFERENT SPRINT INTERVAL TRAINING WORK-TO-REST
RATIOS ON ACUTE METABOLIC AND INFLAMMATORY RESPONSES
By Christopher R. Harnish, Ph.D.
A dissertation proposal submitted in partial fulfillment of the degree of Doctor of Philosophy at
Virginia Commonwealth University
Virginia Commonwealth University, 2014
Advisor: Ronald K. Evans, PhD, Department of Kinesiology and Health Sciences
High intensity exercise is believed to yield greater results on health and human performance than
moderate intensity exercise. Extensive research indicates that not only do high-intensity interval
training (HIT) and sprint interval training (SIT) produce significant improvements in cardiovascular
fitness and disease, they may be more effective at improving long-term metabolic function, including
insulin sensitivity (Si), by producing more mitochondria. Moreover, compliance rates for HIT and
SIT participation are reported to be the same or better than traditional moderate intensity exercise.
Because lack of time is often cited as major hindrance to exercise participation, SIT is also seen as a
time efficient option to improve health and performance. It does appear, however, that repeated
sessions of SIT are needed before overall improvements can be measured. SIT protocols employing
maximal 30 sec sprints with ~5 min rest [a 1:9 work-to-rest ratio (W:R)], have garnered much of the
research focus, while those using minimal rest periods, like Tabata which uses 20 sec sprints and 10
sec rest (2:1 W:R), have been ignored. This may omit a possible SIT option that could influence
acute and chronic adaptations. The role of inflammatory cytokines on Si remains an area of
continued research. While endurance exercise is thought to create an overall anti-inflammatory
environment that stimulates improvement in Si, SIT is often viewed as pro-inflammatory. However,
few studies have provided significant insight into cytokine release following SIT, and none have
explored its impact on Si. In addition, the impact of W:R on cytokine remains speculative at best.
!
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Therefore, the examination of the effect of different sprint protocols of similar total work (kJ) on
performance, metabolic function, and inflammatory response may provide valuable insight into these
adaptive processes.
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CHAPTER 1
INTRODUCTION
Exercise is an effective treatment for many of modern society’s chronic diseases, yet,
exercise remains an underutilized component of disease treatment. In a brief review, Colberg and
Grieco (2009) discussed the central role physical activity can and should play in both the prevention
and treatment of diabetes. Exercise can be effective in reducing body fat (Sigal et al. 2004; Volek et
al. 2005; Thorogood et al. 2011); however, it is far more effective at improving many of the
components of metabolic syndrome, including insulin sensitivity (Sigal et al. 2004; Earnest 2008;
Colberg and Grieco 2009; Hawley and Gibala 2009). Insulin sensitivity (Si) and glucose
effectiveness, or the ability to uptake glucose into the cell, are driven by a number of factors that
include translocation of glucose transporter 4 (GLUT4) inside the cell membrane, and capacity and
mitochondrial density (Bournat and Brown 2010).
It is generally believed that high intensity activity may yield greater positive health outcomes
than traditional moderate intensity endurance activity. Individuals engaging in greater levels of highintensity leisure activities actually improve cardiovascular fitness to a greater extent than lower
intensity activity (Talbot et al. 2000), decreasing one’s risk for disease (Wisloff et al. 2009). Early
work by Dudley et al. (1982) eloquently demonstrated enhanced endurance performance in response
to increased intensity. In fact, high-intensity training has been shown to reverse long-term cardiac
damage (Wisloff et al. 2009), and may yield greater improvements in mitochondrial function and
GLUT4 expression. Despite the clear efficacy of exercise for improving health and fitness in a
variety of populations, participation in exercise or physical activity remains low, with lack of time
being a commonly reported reason (Trost et al. 2001). Thus, researchers and professionals have
sought to develop more time efficient exercise strategies that may yield the same results in less time.
The strong relationship between intensity and improved health and human performance via
high-intensity interval training (HIT), as well as a growing body of research, indicates that HIT
! 1!

provides a more powerful stimulus for the improvement of health and fitness (Hawley and Gibala
2009; Earnest 2008). In the past decade, research using HIT and sprint interval training (SIT) have
shown great promise in not only improving endurance performance to equal or greater levels than
endurance training (Wisloff et al. 2009; Burgomaster et al. 2008; Gibala et al. 2006; Stepto et al.
1999; Acevedo et al. 1989), but also enhancing fat metabolism (Swart et al. 2009), and glucose
tolerance (Babraj et al. 2009). It comes as little surprise to sports scientists, who have known for
years that peak athletic performance demands maximal intensity exercise. Yet, contemporary
exercise advice (ACSM 2009) has recommended similar guidelines to the general public for decades.
Some of the reluctance has come from a fear that high intensity intervals were dangerous for highrisk patients (e.g., those with cardiac disease). However, even in post-infarction heart failure patients,
exercise intensities greater than 90% peak heart rate were shown to be safe, and compliance rates for
such training has been high among a range of populations (Gibala 2011; Wisloff 2011; Wisloff et al.
2009).
Although the metabolic and cardiovascular response to SIT (8-30 sec maximal efforts
interspersed with recovery), might not seem as effective as endurance training, this model has been
shown to be equal or superior to high volume endurance exercise (Whyte et al. 2013, 2010; Trilk et
al. 2011; Brestoff et al. 2010; Richards et al. 2010; Babraj et al. 2009; Burgomaster et al. 2008). In
1996, Tabata et al. demonstrated that just six weeks of training using 20 sec sprints with 10 sec rest
produced significant improvements in VO2

Max

and anaerobic power. Stepto et al. (1999) later

showed that among trained cyclists, 30 sec sprint intervals improved 40 km time trial performance as
much as 4 min VO2

max

intervals; both were superior to other intervals used. Since that time,

researchers (Burgomaster et al. 2008, Gibala et al. 2006) have demonstrated that supra-maximal 30
sec Wingate SIT produce similar acute metabolic/biochemical changes in the trained musculature as
more traditional endurance training. Subsequent data from these researchers has shown that from a
cell signaling perspective, SIT is more closely related to endurance than strength training, acting as a
!
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potent stimulus for PGC-1α expression by up regulating AMPK and p38 MAPK signaling pathways
(Gibala et al. 2009).
Based on the preponderance of research currently, it is apparent that how hard one exercises
(i.e., intensity) strongly influences the adaptive process. This is common knowledge to athletes and
coaches, who have long used interval training for peak performance. Unfortunately, adoption of
optimal training methods for the general and special populations has lagged. Nonetheless, it is
widely accepted that optimal endurance performance requires training at or near maximal intensity
(Laursen 2010). In addition, the W:R can have a dramatic impact on both cardiovascular, muscular,
and endocrine response to exercise (Ziemann et al. 2011; Gray et al. 1993; Hakkinen and Pakarinen
1993). For example, Tabata et al. (1996) utilized a 2:1 W:R in their 6-week SIT program to produce
significant improvements in aerobic and anaerobic fitness. Follow-up research (Tabata et al. 1997)
indicated that this 20 sec sprint program achieved maximal stimulation of both aerobic and anaerobic
capacity, which was significantly higher than a 1:4 W:R using 30 sec Wingate sprints. Thus,
mitochondrial ATP production should be higher using the 2:1 Tabata protocol. This latter point is
important, as ATP turnover is believed to be a key variable in mitochondrial biogenesis, aerobic
enzyme production and acute metabolic improvements (Thyfault 2008), and may drive long-term
adaptations (Gibala et al. 2009, Coffey and Hawley 2007). The former premise was supported by
Whyte et al. (2013) who demonstrated that a single maximal 200 sec extended sprint significantly
improved 24-hr insulin sensitivity, whereas a single session of four Wingate sprints of similar kJ
expenditure did not.
Presently, research indicates that six or more bouts of SIT are needed to produce significant
improvements in performance and Si (Whyte et al. 2013, 2010; Trilk et al. 2011; Brestoff et al. 2010;
Richards et al. 2010; Babraj et al. 2009; Burgomaster et al. 2008). It remains unclear whether a
single bout of SIT using a low W:R, like that proposed by Tabata et al. (1996), could improve acute
Si or other performance markers, as many of the mechanisms for such a response remain undefined.
!
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For example, Burgomaster et al. (2008) showed that six weeks of SIT produced similar
improvements in lipid and carbohydrate oxidation and mitochondrial biogenesis compared to
endurance training encompassing ten-times the total work expenditure (225 kj vs. 2250 kj). More
recently, researchers have shown that 2-weeks of 30 sec Wingate SIT with ~5 min rest (1:9 W:R)
improves metabolic function in obese women (Trilk et al. 2011), young adults (Brestoff et al. 2010;
Richard et al. 2010; Babraj et al. 2009), and obese men (Whyte et al. 2010). Only White et al. (2013)
have shown an acute improvement in Si, but that was following a maximal 200 sec continuous effort.
If ATP flux is a critical factor, then one could surmise that the Tabata protocol (Tabata et al. 1997
and 1996) would also result in an improvement in Si. It also raises questions about the mechanisms
for chronic SIT adaptations.
It has been suggested that SIT adaptations are short lived and represented early adaptations.
Two unrelated studies addressed this issue, and in doing so, validated the Overload Principal in
untrained and trained individuals. For example, Nordsborg et al. (2010) compared the molecular
response via alterations in mRNA PGC-1α following HIT in both untrained and trained (1 yr training
and VO2

Peak

55 ml.kg-1.min-1) individuals. Trained participants did HIT sessions at 85% of the

untrained VO2

Peak

power. As expected, training at the same absolute power did not yield any

significant changes in the trained group, while 85% of each group’s max (i.e., same relative power)
showed significant increases in mRNA PGC-1α. Although not surprising, another interesting finding
was that lactate levels for trained individuals were significantly lower at the same absolute workload.
The latter finding brings into question the role of homeostatic disruption to elicit exercise
adaptations, as well as the role of reactive oxygen species (ROS), like H2O2, and lactate
accumulation, implicating both in the up-regulation of PGC-1α (Lira et al. 2010; Hashimoto et al.
2007). Finally, further support for SIT impact on endurance adaptations were seen in even highly
trained cyclists (VO2 peak ~70 ml.kg-1.min-1), who, after completing a single session of SIT, saw gene
expression in several key mitochondrial markers, supporting the notion that it is the relative intensity
!
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of training (i.e., near the individuals “max”) that elicits improvements (Niklas et al. 2010). This
relative response may have important training implications for non-ambulatory populations,
including persons with spinal cord injury (SCI), who suffer from a multitude of cardiovascular and
metabolic ailments. Training research among those with SCI is severely deficient; for additional
information on SCI please refer to Chapter 2, and for an extended review of SCI please refer to
Appendix A.
The implications of homeostatic disruption suggest that the exercise inflammatory response
could play an important role in exercise adaptations. Endurance exercise is generally considered to
be anti-inflammatory (Petersen and Pedersen 2006) in the sense that on balance, anti-inflammatory
cytokines like IL-6 and IL-10 exceed inflammatory cytokines like TNF-α (Ropelle et al. 2010;
Pedersen and Fischer 2007; Petersen and Pedersen 2005), and that the release of IL-6 is proportional
to the intensity and muscle mass utilized during training (Fischer et al. 2006). Further, IL-10 has
been proposed as a major influence on Si at rest (Staczkowski et al. 2005), and Steensberg et al.
(2003) have shown that IL-6 infusion enhances IL-10 release.
Alterations in inflammatory cytokines (e.g., IL-6, IL-10, and TNF-α) have been implicated as
mediators of glucose regulation at rest (Harnish et al. 2005; Staczkowski et al. 2005, Pedersen et al.
2001), as well as during and after exercise (Brandt and Pedersen 2010; Hong et al. 2009; Pedersen
and Fischer 2007; Fischer et al. 2006; Petersen and Pedersen 2005; Febbraio and Pedersen 2002;
Pedersen et al. 2001). Moderate to high intensity endurance exercise is known to be a potent stimulus
for IL-6 release from muscles (Febbraio and Pedersen 2002), but less is known about short duration
maximal or sprint exercise. For example, a 2-fold increase in IL-6 was seen in exercise as short as 6
min at VO2 max (Nielsen et al. 1996), and following run sprint training (Meckel et al. 2011, 2009)
Figure 1 summarizes the current proposed impact of muscle-derived IL-6 on GLUT-4 and overall
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glucose uptake. As indicated, IL-6 is believed to both stimulate GLUT-4 activity directly, as well as
stimulate IL-10 release, which itself may improve Si (Steensberg et al. 2003).
In contrast to endurance exercise, SIT has been described as more pro-inflammatory (Meckel
et al. 2011, 2009; Nemet et al. 2009). If this is correct, it might help explain the lack of acute
improvement in Si. In general, the literature regarding the inflammatory cytokine (e.g., IL-6, IL-10,
and TNF-α) response following SIT appears inconclusive. For example, Meckel et al. (2011; 2009)
showed that IL-6, considered pro-inflammatory by these researchers, peaked 1-hr after run sprint
training, while Brestoff et al. (2010) showed inconclusive results for IL-6 and TNF-α. Whether
inflammatory cytokines influence acute improvements in Si following SIT remain to be seen, as no
study to date has examined this possible mechanism. Additionally, W:R can dramatically impact
metabolic stress, cardiovascular demand, and endocrine response during and following exercise
(Ziemann et al. 2011; Tabata et al. 1997; Gray et al. 1993; Hakkinen and Pakarinen 1993). Little is
known about the impact of W:R on cytokine release.
In spite of the large body of evidence supporting the efficacy of long-term! SIT, questions
remain regarding the mechanisms for SIT adaptations, as well as the acute (i.e., 1 – 24 hr post)
response following SIT. In particular, W:R may influence acute adaptations, as well as the
inflammatory response. Therefore, it would be valuable to examine the effect of different sprint
protocols of similar total work (kJ) on performance, metabolic function, and inflammatory response.
In order to further evaluate SIT, we performed two separate studies to examine if SIT could
be applied to upper extremity training, and a second to ascertain if an alteration in W:R could clarify
some of the possible mechanisms for acute SIT. In the first study (see Chapter 2) , a group of men
with chronic spinal cord injury engaged in 2 weeks of arm crank sprint training. Positive influence of
metabolic factors could be critically important in improving the health of this population. In a
follow-up study (see Chapter 3), energy expenditure was matched between Wingate SIT and 5 min
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of Tabata training using 20 sec of sprinting with 10 sec of recovery. In this latter study, we sought to
explore whether the compressed W:R would improve Si, and whether those changes were related to
inflammatory cytokines, cited as a key player in endurance training improvements in Si.

!
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Figure 1. Schematic summary of the initiation of muscle-derived IL-6 release and the subsequent role that
IL-6 plays in various organs that lead to enhanced glucose uptake. IL-6 promotes GLUT-4 activation in the
brain, liver, and even skeletal muscle, as well as promoting IL-10 production. IL-10 blocks TNF-α and
macrophage constituents, which interfere with GLUT-4 (Adapted from Febbraio and Pedersen 2002;
Pedersen and Fischer 2007).
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CHAPTER 2
The effects of two weeks of arm crank sprint interval training in men with chronic spinal cord
injury (SCI)
Research conducted at the Hunter Holmes McGuire VAMC, Richmond, VA
Christopher Harnish, M.S.
Dept of Health and Human Performance
Virginia Commonwealth University
Richmond, VA 23219
Ph 804.592.0512
Fx 804.828.1947
Harnishc@vcu.edu

Roy Sabo, Ph.D.
Dept. of Biostatistics
School of Medicine
Virginia Commonwealth University
Richmond, VA USA
804.828.3047
rsabo@vcu.edu
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ABSTRACT
The purpose of this study was to examine the performance and metabolic effects of two weeks of
sprint interval training (SIT) in men with spinal cord injury (SCI). Eight males aged 47 (44, 56.8)
yrs, 180.8 (2.4) cm tall, 85.1 (6.9) kg, and a peak 2 min power output of 90 (60, 135) W with chronic
SCI, T1-T10 completed three OGTT's - baseline, 2 weeks later (Pre), and 48 hrs Post training, with
corresponding 24 hr dietary recall during each. Six SIT sessions over 2-weeks were performed on a
Monark 891E ACE. Subjects cranked against 3.5% body mass for 30 sec, completing 4 sprints
session 1, then 5, 5, 6, 6, and 7 sprints in the final session. All data are presented as medians (Q1,
Q3), and a Wilcoxon test (α=0.05) was used to test for significant pre and post session changes.
Dietary analysis indicated subjects consumed 1907 (1288, 2751) kcal, consisting of 50.5 (38.7,
57.8)% CHO and 31.0 (26.3, 37.9)% Fat. Work during the first four sprints of each session increased
(p=0.13) from 23.0 (18.4, 26.3) to 25.7 (19.8, 32.1) kJ between the first session and last. AUC for
either glucose or insulin did not significantly change and were and highly variable. ISI-Cederholm
insulin sensitivity (Si), was 151.6 (145.2, 176.0) baseline, 179.2 (162.7, 190.8) Pre, and 165.2
(141.0, 202.3) Post. Plasma NEFA area under the curve was significantly improved (p=0.008),
however. In conclusion, two weeks of ACE SIT was effective at reducing NEFA in men with SCI,
but did not improve insulin sensitivity. These data indicate that ACE SIT may be an effective adjunct
training modality for those with SCI and other non-ambulatory populations.
Key Words
Spinal cord injury, sprint interval training, insulin sensitivity, arm crank ergometry, OGTT
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INTRODUCTION
More than 6 million (~2%) Americans are living with a spinal cord injury or disorder (4).
Numerous studies have shown that up to half of persons with spinal cord injury (SCI) are obese, with
nearly 70% of persons with SCI exhibiting two or more components of Metabolic Syndrome
(6,8,9,18). Poor glucose and insulin regulation, as well as dyslipidemia, are also common (25). Due
to the close relationship between metabolic syndrome and both obesity and blood sugar
management, mitigating either or both of these conditions is a priority for many populations,
including SCI. Little is known, however, on the impact of specific ACE interventions among SCI.
Upper extremity training is effective at improving central and peripheral fitness, and may
transfer to lower extremity fitness (2,23). Although training the upper extremities does improve force
production and endurance of the muscles trained, intensity appears to be a critical factor in upper
extremity fitness and transfer to lower extremity fitness (23). Nevertheless, the data are sparse for
SCI training interventions, particularly high-intensity protocols. Moreover, the potential metabolic
benefits of SIT could provide substantial benefit to the myriad of metabolic disorders common
among SCI.
Exercise can be effective in reducing body fat (24) and improving many of the components of
metabolic syndrome, like insulin sensitivity (5,7,13). The link between improved mitochondrial
function and glucose transporter (GLUT) 4 expression led Earnest (7) to hypothesize that highintensity interval training (HIT) provides a more powerful stimulus improving insulin sensitivity
than moderate aerobic exercise, relating specifically to the aerobic metabolic processes (e.g., aerobic
glycolysis, beta oxidation, and mitochondrial biogenesis). Moreover, greater levels of high-intensity
leisure activities improve cardiovascular fitness, decreasing one’s risk for disease (22,26).
Results by Gibala and others (1,3,10) show the powerful endurance-like impact that sprint
interval training (SIT) has on oxidative capacity and metabolic function. For example, Burgomaster
et al. (3) showed that six weeks of SIT produced similar improvements in lipid levels, carbohydrate
!
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oxidation, and mitochondrial biogenesis compared to endurance training encompassing ten-times the
total work expenditure (225 kJ vs 2250 kJ). More recently, Babraj et al. (1) showed that six sessions
of SIT improved insulin sensitivity by 37%, as well as a significant reduction in non-esterified fatty
acids (NEFA). Unfortunately, many populations lack adequate ambulation necessary to effectively
utilize leg ergometry (12), and may be limited to upper extremity exercise, with arm crank ergometry
(ACE) being common.
The purposes of this study were to examine the efficacy of six sessions of ACE SIT on sprint
performance and metabolic factors, including insulin sensitivity and plasma NEFA’s. We
hypothesized that ACE SIT would improve insulin sensitivity (ISI-Cederholm), reduce plasma
NEFA,’s and improve repeated Wingate performance from pre-regimen levels in men with SCI.
METHODS
Experimental Approach to the Problem
The experimental protocol (Figure 1) was similar to previous SIT studies (1,3,10). Due to
difficulty in recruiting and transporting persons with SCI, we utilized a two-week control period
where two separate oral glucose tolerance tests (OGTTs) were compared when lifestyle and activity
were unchanged. During this two-week period, subjects performed baseline and pre-training (Pre)
OGTT with 24 hr dietary recall, and DXA body composition analysis. Within this two-week contol
period, subjects were familiarized with ACE Wingate training no less 5 days prior to the second
OGTT to prevent any possible effect on blood test. Once completed, each participant began their
sprint training within 36 hrs after the Pre OGTT. The sprint training took place over a period of 2
weeks with a total of six training sessions. A final post training (Post) OGTT was performed
between 48 and 60 hrs of the final training session. Utilizing this protocol, we surmised that baseline
and Pre blood variables would not change, while those same variables would change -- as shown in
other studies (1,3,10) -- after six sessions of SIT. Enrollment and testing began in June 2010 and
were concluded approximately 18 mo later.
!
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Subjects
All experimental protocols were reviewed and approved by the McGuire VAMC institutional
review board and comply with the Declaration of Helsinki. All participants were actively recruited
through word of mouth, flyers and call lists, with individuals being both veterans visiting the Hunter
Holmes McGuire Veterans Administration Medical Center (VAMC) and individuals living in the
greater Richmond, Virginia (USA) Community. Subjects were enrolled in the study following
completion of the McGuire IRB approved informed consent document. A detailed medical history
and ACSM risk factor assessment was performed for all participants and each subject was reviewed
by a board-certified physician. Only individuals considered paraplegics (i.e., T1–L2) AIS-A through
D for 3 months or longer were considered for the study. Individuals classified as High Risk based on
established American College of Sports Medicine criteria, persons with known orthopedic
limitations, diabetes mellitus (fasting glucose > 126 or HgbA1c > 7.0), hypothyroidism, renal
disease, uncontrolled autonomic dysreflexia, recent (within 3 months) deep vein thrombosis, or
pressure ulcers > Grade II were excluded from participation. Twelve sedentary men with T1 – T10
SCI initiated the study, with eight completing the entire protocol; these eight were aged 47 (44, 56.8)
yrs, 180.8 (2.4) cm tall, 85.1 (6.9) kg, and a peak 2 min power output of 90 (60, 135) W. The study
was conducted over the course of 18 months.
Procedures
Subjects were instructed to maintain their usual diet throughout the study and to consume
similar meals the day before each OGTT; a standard 24 hr dietary recall form for the day prior to the
OGTT were used to instruct subject’s on maintaining their dietary habits and used for later
comparison; subjects were also instructed to consume 8-16 oz of water prior to their arrival for
testing. During the pre-training control period, each subject completed one to VO2 Peak testing was
used to assess physical readiness and determine maximum 2 min power after the first OGTT. Testing
was performed using a Lode upper extremity ergometer (Electro-Med Corporation, Flint, MI).
!
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Subjects performed the test in their own stabilized wheelchair with appropriate seating, trunk
support, leg wraps, abdominal binder and protective hand mitts provided. Each subject cranked at 70
RPM against no resistance for 3 min before work rate was increased by 15 W every 3 min until
volitional exhaustion was reached. VO2 and HR were measured continuously using a Cosmed K4b2
(Rome, Italy) and stored for later analysis. Subjects were familiarized with the training protocol no
less than 5 days prior to training to mitigate any influence on the Pre OGTT.
Sprint training was performed using a mechanically braked Monark 891E arm crank ergometer
(ACE) (Monark Exercise AB, Sweden) while sitting in their own stabilized wheelchair with
appropriate seating, trunk support, leg wraps, abdominal binder and protective hand mitts provided.
Following 10 min of unloaded warm-up at 30-50 rpm, each subject cranked as fast as possible for 30
sec against a resistance equivalent to 0.035 kg/kg (3.5%) body weight; this resistance was tested
during the pilot phase of this study and has been shown to be suitable for thoracic level persons with
SCI (14). Subjects cranked while being provided with vigorous verbal encouragement throughout
each sprint. Peak and mean power (W) and total work (kJ) were recorded using the software
provided with the ergometer. Each sprint was followed by ~5 min of rest or slow reverse pedaling.
The initial training session included four sprints progressing to five sprints in sessions 2 and 3, six
sprints in sessions 4 and 5, and finally seven sprints in the final session. Sessions were separated by
at least 48 hrs, but no more than 72 hrs (i.e., one weekend). During sessions 1 and 6, 5 µl blood
lactate samples were taken from the subject’s earlobe using a small plastic lancet and immediately
analyzed using a Lactate Scout Analyzer (EKF diagnostic sales GmbH, Barleben/Magdeburg).
Samples were taken prior to training, after sprint 1, 4 and 7 (during session 6), and 1 and 3 min post
exercise. Each training session lasted approximately 30 min. Due to the increase in the number of
sprints performed during training, the relative improvement in overall sprint work capacity was
compared using the total kJ expenditure
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All OGTT were performed between 0800 and 1000 hours, and each subject’s tests were
conducted at the same time (+ 5 min) of the first test. Subjects refrained from performing any
strenuous physical activity for a period of 72 hrs prior to baseline and Pre OGTT, and arrived at the
laboratory following at least a 12 hr overnight fast. Venous blood samples (~10 ml) were collected
by venupuncture before ingestion, and at 60, 90 and 120 min after ingestion of 75 g glucose (NOW
Foods, Bloomingdale, IL) dissolved in 100 ml of water. Plasma was separated by centrifugation (15
min at 7000 rpm) and stored at -20°C until analysis of glucose, insulin, and NEFA concentrations.
Plasma glucose concentrations were measured using an auto-analyzer glucose oxidase method, while
plasma insulin concentrations were determined by ELISA (R&D Systems, Inc, Minneapolis, MN).
Plasma NEFA concentrations were determined by a colorimetric assay (Wako Chemicals, Germany)
using a modified protocol. Briefly, 3.75 µl of plasma samples and standards of known concentration
were pipetted into a 96-well plate. 75 µl of color reagent A were added to each well and incubated at
37°C for 10 min. 150 µl of colour reagent B were added and incubated for a further 10 min at 37°C.
The plate was then removed from the incubator and allowed to cool to room temperature prior to the
absorbance being read at 550 nm. In order to assess normal intra-individual variation in response to
an OGTT over a period of several weeks as used in the present study, all subjects performed the
initial OGTT prior to any testing in week 0 and compared to the Pre training test at week 2.
Statistical Analyses
Data were analyzed using commercially available software (Jump 11.0, SAS Institute Inc,
Cary, NC). Due to the relatively small final sample size, all measurements are presented as medians
and quartiles (Q1, Q3), except where noted. Area under the curve (AUC) was calculated using the
trapezoidal rule and peripheral insulin sensitivity (Si) was estimated using ISI-Cederholm.

!

75000+(G0-G120)*1.15*180*0.19*BW
120*Gmean*log(IMean)!

BW = body weight, G0 and G120 are plasma glucose concentration at 0 and 120 min (mmol·l-1), and
Imean and Gmean are the mean insulin (mU·l-1) and glucose (mmol·l-1) concentrations during the
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OGTT. The Wilcoxon Signed-Rank test (α=0.05) was used to compare AUC values pre- to postregimen. In these tests we hypothesize a decrease in AUC for each measurement after the sprint
interval regimen, against a null hypothesis of no change.

For each measurement, the median

difference in AUCs and quartiles (Q1, Q3) are reported due to the small sample size. A 5%
significance level was used for all tests.
RESULTS
The average work during sprints increased from 5.75 (4.61, 6.86) to 6.13 (4.78, 7.75) kJ the
first session and last, or a nearly 7% improvement (p = 0.13). Table 1 shows the median (and IQR)
AUC both pre- and post-test (as well as the median differences (and IQR) in absolute measures).
AUC changes for either glucose (p = 0.55) or insulin (p = 0.38) failed to show significant changes.
ISI-Cederholm 151.6 (145.2, 176.0) baseline, 179.2 (162.7, 190.8) Pre, and 165.2 (141.0, 202.3)
Post, also did not show significant changes (0.60); close inspection of the individual data (Figure 2)
show large variation between the three OGTT periods. Further, the variability could not be explained
by differences in dietary intake. Dietary analysis indicated subjects consumed 1907 (1288, 2751)
kcal, consisting of 50.5 (38.7, 57.8)% CHO and 31.0 (26.3, 37.9)% Fat, without significant
variations between tests. There was a significant reduction in NEFA (p = 0.008), as the NEFA AUC
post intervention was -0.3 units lower than the NEFA AUC pre-intervention (Table 2).
DISCUSSION
The purpose of this study was to evaluate the efficacy of arm crank SIT for paraplegic men.
Based on the available research for leg sprinting (1,3,10) and upper extremity training (20,23), we
speculated that ACE SIT could improve sprint performance and metabolic factors in men with
chronic SCI. While this preliminary study could not find a significant improvement in glucose
tolerance or insulin sensitivity, we did see a significant reduction in NEFA. These findings suggest
that while SCI may exhibit too much variability in carbohydrate metabolism to make oral glucose
tolerance tests sensitive enough for training evaluations, but NEFA measurement may be a useful
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alternative in men with SCI. Additionally, the study is an important step in optimizing ACE training
for SCI and others, which have long been ignored in lieu of lower extremity training.
As opposed to earlier research, SIT failed to influence carbohydrate metabolism or insulin
resistance (1,10). For instance, Babraj et al. (1) reported a coefficient of variation in glucose AUC of
less than 5%, whereas we saw as much as a 40% increase in our subjects. Further, our comparative
data included four individuals who initiated but did not complete the study, two of which saw an
improvement in Si during the control period. Excluding dietary influences, which were monitored, it
is likely that the high day-to-day variability in glucose and insulin response was too great to
overcome with upper extremity exercise alone. It is well documented (9,18,20,21,25) that persons
with SCI suffer a multitude of metabolic disruptions. It is believed that nearly 70% of persons with
SCI suffer from obesity (21), while two-thirds suffer impaired fasting glucose (25). Our subjects
reflected typical body fat levels (> 30%) seen after SCI, and ACE has been shown to produce lower
work outputs (9). Moreover, other researchers have encountered similar problems using the OGTT
(Personal Communication, T. Ryan 2012), and even the intravenous glucose tolerance test (IVGTT)
data (unpublished) from our lab suggest that it may not be an ideal test to assess metabolic
improvements for persons with SCI.
In contrast to glucose and insulin, the significant reduction in plasma NEFA AUC indicates
that blood lipids may be more useful metabolic training marker in persons with SCI (20). Further,
our 2-hour trends in NEFA levels relate closely to those published by Babraj et al. (1) follow lower
extremity sprints. Elevated plasma NEFA levels have been shown to directly and indirectly impair
insulin sensitivity (11,17), and that persons with SCI show elevated NEFA levels (8,26), making
reductions an important outcome with training. A reduction in NEFA in the blood could indirectly
improve insulin sensitivity (17). Moreover, long-term training utilizing SIT and resistance training
could significantly impact factors other than just glucose metabolism. For example, Nash et al. (20)
demonstrated that three months of combined aerobic and resistance circuit training significantly
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improves both cardiovascular fitness and blood lipid profiles in men with SCI, while Jacobs (15)
demonstrated impressive cardiovascular and power enhancements from heavy resistance training
alone. Therefore, SIT may afford an additional modality for training and overall improvement in
quality of life.
In order to make relative work comparisons, we used the total kJ for the first four sprints of
each session. The paraplegics in this study were all untrained males, but showed a high training
capacity with an approximate 7% improvement in total sprint work over the course of six sessions.
These data, while not significant, showed a consistent increase in work output each training session;
the impact of learning is likely minimal considering subjects performed 4 sprints in the first session,
and 26 sprints prior to the final training session. These data suggest that men with SCI can tolerate
the addition of some SIT, which would improve overall upper extremity power, an important fitness
component for wheelchair propulsion and activities of daily living (15,16,19,27). For example, loss
of upper extremity strength and power significantly increases one’s risk for premature mortality (19),
and strength and power have a profound influence on one’s ability to perform activities of daily
living and wheelchair propulsion (16,27).
Spinal cord injury creates a physiological environment driven by catabolic and inflammatory
responses (8,25) that is both complex and deleterious to the individual’s health and wellness. Despite
the mixed results on “metabolic fitness”, at least compared to lower extremity SIT, ACE SIT may be
a useful adjunct modality for persons with SCI. Furthermore, it is likely that healthier, nonambulatory persons could benefit more from ACE SIT (12). In addition, ACE SIT may provide
tertiary benefits to activities of daily living. More research is needed to elucidate the effects of longer
duration interval programs for those with SCI.
PRACTICAL APPLICATIONS
This study is an important step towards optimizing upper extremity protocols for individuals
with or without spinal cord injuries. These findings demonstrate that persons with SCI have a high
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work capacity, which, when coupled with the body of literature using combined resistance and
cardiovascular training, suggest that broad training prescriptions can be considered for those with
SCI. Contemporary research demonstrates the importance of power in overall health and functional
ability. SIT can also provide enhanced power for wheelchair propulsion, reducing physical strain and
improving one’s ability to perform activities of daily living. While exercise-induced metabolic
improvements for persons with SCI are variable, SCI training programs emphasizing training to
enhance strength and power may ultimately improve long-term participation in daily physical
activity, and prove more beneficial over time than endurance focused training programs. Such
training could be accomplished via arm crank ergometry, wheelchair sprints, or with the use of
circuit resistance training. Strength and conditioning specialists and personal trainers can effectively
incorporate high-intensity sprint interval training into programs for persons with SCI , as well as
other non-ambulatory populations.
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Table 1: Summary of Pre- and Post-Test Areas Under Curves for glucose, insulin and NEFA. Pre and post
intervention ISI-Cederholm results are also shown.
Pre
Measure
Glucose
Insulin
NEFA
ISI-Cederholm

!

Post

Median
77
143
1.5

IQR
(68, 80 )
(99, 258)
(1.1, 1.6)

Median
79
139
1.2

IQR
(62, 90)
(96, 171)
(0.5, 1.4)

169

(149, 194)

170

(147, 201)
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Difference
Median
IQR
2.9
(-3 , 8)
-35
(-98, 18)
-0.3
(-0.6, 0.1)
-9
(-19, 31)

p-value
0.547
0.383
0.008
0.7422

Figure 1. Experimental design for 2 weeks of sprint interval training in individuals with SCI.
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CHAPTER 3
Comparison of Two Different Sprint Interval Training Work-to-Rest Ratios on Acute
Metabolic and Inflammatory Responses
ABSTRACT
Purpose: The purpose of this study was to compare how W:R influences Si and inflammatory
responses following a single bout of SIT. It was believed that when matched for energy expenditure,
SIT using brief rest periods (W:R = 2:1) would elicit an improvement in Si and larger cytokine
response than SIT using long rests (W:R = 1:9). Methods: 12 men and 2 women completed a crossover comparison of two SIT interventions – Tabata (TAB), 10X 20 sec sprints/10 sec rest using 5%
of body weight, and Wingate (WIN), 5X 30 sec sprints with ~270 sec rest using 7% of body weight.
Baseline measures and oral glucose tolerance tests (OGTT) were repeated one week apart and
included IL-6, IL-10, and TNF-α. Blood samples (~10 ml) were taken at baseline, immediately
following the training session, 1-hr after each training session, and prior to the 24-hr post-exercise
OGTT. All data are presented as means + SE. Insulin sensitivity (Si) was estimated using the
Cederholm index. The effect of SIT on Si following SIT sessions at baseline and 24 hr were analyzed
using repeated measures ANOVA with post hoc Tukey tests (α=0.05). Results: Subjects were 23.8
(±0.9) yrs old, 16.9 (±1.7) % body fat, with a mean VO2 Peak of 42.0 (±2.0) ml.kg-1.min-1. Mean power
during WIN was significantly higher (p<0.0001), but kJ expenditure between TAB (64.7 + 3.5) and
WIN (68.0 + 3.5) was similar. Si 24-hr was suppressed after both SIT sessions, and was significantly
lower following WIN (p=0.031). There were no significant differences in inflammatory response
between TAB and WIN. Neither TAB (1.95 + 0.30 pg.ml-1) nor WIN (1.96 + 0.30 pg.ml-1) produced
peak IL-6 levels significantly above baseline (0.85 + 0.30 pg.ml-1). In contrast, resting IL-10 (3.19 +
0.32 pg.ml-1) increased significantly immediately following TAB (5.65 + 0.35 pg.ml-1; p < 0.0001)
and WIN (5.53 + 0.33 pg.ml-1; p < 0.0001), returning to baseline within 1-hr. Similarly, resting TNF-
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α (6.21 + 0.68 pg.ml-1) significantly increased immediately following TAB (9.75 + 0.71 pg.ml-1; p =
0.0118) and WIN (9.75 + 0.71 pg.ml-1; p = 0.0118). There was a weak positive relationship (r = 0.24,
p= 0.0364) between IL-6 and IL-10, but a strong significant relationship (r = 0.71, p < 0.0001)
between TNF-α and IL-10. Conclusions: A single bout of SIT, regardless of W:R, may slightly
reduce insulin sensitivity 24-hr after training, despite an increase in IL-10, which has been shown to
improve insulin sensitivity. Additionally, the release of IL-10 may be mediated by an increase in
TNF-α. These data indicate that SIT produces a pro-inflammatory response without acute
improvement in metabolic factors, like insulin sensitivity. More research is needed to elucidate the
acute and chronic adaptations to SIT.

Key words: SIT, Cytokines, Myokines, Insulin Sensitivity, Wingate, Tabata, OGTT
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INTRODUCTION
High-intensity interval training, including sprint interval training (SIT), has been proposed as
a more powerful stimulus to improve insulin sensitivity (Si) than moderate aerobic exercise (Earnest
2008). Repeated sessions of SIT using long rest periods (i.e., low work-to-rest ratio) elicit
improvements in endurance performance (Burgomaster et al. 2008), as well as metabolic function
(Whyte et al. 2013, Gibala 2011, Brestoff et al. 2010, Richards et al. 2010, Babraj et al. 2009). The
underlying mechanisms for these chronic improvements are not fully understood. Moreover, the
work-to-rest ratio (W:R) is an important mediator of metabolic, cardiovascular, and endocrine
responses during and after interval and resistance training (Gray et al. 1993; Hakkinen and Pakarinen
1993), but has not been studied in relation to Si.
While acute and chronic endurance exercise improves Si, it appears that only at least 6six
sessions of SIT are needed to improve Si (Whyte et al. 2013; Brestoff et al. 2010; Richards et al.
2010). For example, Babraj et al. (2009) showed that six sessions of SIT improved insulin sensitivity
by 37%, while other groups have reported similar findings among obese men (Whyte et al. 2010) and
obese women (Trilk et al 2011). In contrast, a single bout of SIT appears ineffective at improving Si
(Whyte et al. 2013; Brestoff et al. 2010; Richards et al. 2010). Whyte et al. (2013) proposed that the
4-5 min rest periods (1:8-1:10 W:R) used in many studies does not provide sufficient stimulus on the
mitochondria and is independent of kJ expenditure. This was supported by data showing that a single
continuous sprint of ~200 sec could improve Si, which furthered Thyfault’s hypothesis (2008) that
ATP flux is a critical variable for acute Si improvement. Extrapolating further, one could expect that
SIT using brief rest periods could have a similar impact. Early work by Tabata et al. (1996),
indicated that just 4 min of 20 sec of sprinting with 10 sec of recovery (2:1 W:R) significantly
improve VO2 max and sprint performance, compared to moderate intensity endurance training, which
improved only VO2 max. Despite these impressive findings, follow-up research using Tabata training
is lacking.
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There are many possible mediators of insulin sensitivity and glucose uptake following
exercise. Inflammatory cytokines have been implicated as mediators of glucose regulation at rest
(Staczkowski et al. 2005; Pedersen et al. 2001;), and following endurance exercise (Pedersen and
Fischer 2007; Fischer et al. 2006; Petersen and Pedersen 2005; Febbraio and Pedersen 2002;
Pedersen et al. 2001). On balance, endurance exercise is viewed as anti-inflammatory, with both IL-6
and IL-10 key players in the post-exercise improvement in glucose uptake (Pedersen 2011). In
contrast, SIT has often been viewed as pro-inflammatory (Meckel et all. 2011, 2009; Nemet et al.
2009) with significant increases in IL-6 following training. Therefore, it is unclear whether these
inflammatory cytokines are influencing the metabolic changes following exercise. Moreover, it is
unclear whether W:R influences either of these factors.
The purpose of this study was to compare how W:R influences Si and inflammatory
responses following a single bout of SIT. It was believed that when matched for energy expenditure,
SIT using brief rest periods (W:R = 2:1) would elicit an improvement in Si and larger cytokine
response than SIT using long rests (W:R = 1:9).
METHODS
Participants
A total of 13 men and 2 women were actively recruited for the study. . All subjects were
evaluated for safe exercise participation using an ACSM risk factor assessment and informed of the
purposes of the study before signing an informed consent document approved by the Virginia
Commonwealth University IRB. Inclusion criteria included men and women between the ages of 1835 years old who were minimally active, but had a body fat < 25% men and 32% women. Exclusion
criteria were any person exceeding the body fat cut off, orthopedic limitations preventing full
participation in the study, pre-diabetes or diabetes mellitus, reported hypothyroidism, renal disease,
and/or anyone considered High risk for exercise participation based on current ACSM clinical
guidelines.
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Experimental Protocol
The experimental protocol (Figure 1) was similar to previous SIT studies, and consisted of a
one-week intra-subject control period. During this period subjects performed baseline (B) and pretraining (PRE) oral glucose tolerance tests (OGTT). Subjects then completed two different acute SIT
protocols – Tabata and Wingate, utilizing a cross-over trial design, with each training bout separated
by no less than one week. Half the subjects completed the Tabata first, while the other half
completed the Wingate first. All exercise took place using a mechanically braked Monark Peak Bike
(Monark Exercise AB, Sweden). Blood samples (~10 ml) were taken immediately following, and 1
hr after each training session, as well as 24 hr after exercise; this corresponded to the initial resting
sample prior to the post-exercise OGTT.
Dietary Control
Each subject was asked to complete a 3-day dietary recall form prior to completing any blood
analysis. Dietary analysis were performed by a registered dietician for later comparison, and subjects
were asked to pick one day within the recall and repeat those meals the day before each OGTT,
recording the meals for those days. Additionally, each participant completed all training sessions
after a 12-hr fast, including alcohol and caffeine, and they abstained from significant activity 24-hr
prior to all exercise sessions and OGTT’s.
Preliminary Testing and Evaluation
On the initial assessment day (Day 3) and during the OGTT, subjects completed body
composition analysis using bioelectrical impedance analysis (RJL Quantum IV, RJL Systems, Inc.,
Clinton Township, MI), where subjects lay supine for a period of 20 min to allow body fluids to
equilibrate across the body. During this time small electrodes were placed on right ankle and wrist.
Body composition was then estimated using web based software (RJL Interactive Online BIA, RJL
Systems Inc., Clinton Township, MI). Following the initial OGTT, physiologic testing included
bicycle VO2
!
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testing. Testing was completed on the Monark bike which was equipped with an
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SRM power meter (SRM Service Center, Inc., Colorado Springs, CO); peak and mean power (W)
were measured for each stage. VO2 and HR were measured continuously using a Parvo OneMax
system (Parvo Medics, Salt Lake City, UT) and Polar HR monitor (Polar Electro Inc., New Success,
NY), respectively. Subjects were instructed to pedal at their preferred cadence throughout testing.
The initial workload was set at 1.5 KP with an approximate work rate of 100 W, increasing by 0.5
KP every 2 min until volitional exhaustion was reached, or the subject could not maintain their
chosen cadence.
Exercise Protocols
All SIT sessions began between 0700 and 0900, and each subject’s sessions took place at the
same time of the morning. All sprint bouts began with a 10 min unloaded warm-up at ~70 rpm.
Subjects then pedaled against a resistance equivalent to 7% (0.07 kg.kg-1) body mass for Wingate
sprints, and a slightly lower 5% (0.05 kg.kg-1) body mass for Tabata. The former resistance has been
shown to produce optimal power output and reliable measurement (Foster et al. 1995), while the
latter was shown to be optimal during pilot data work prior to the study. Subjects were instructed to
pedal as fast as possible for ~2 sec before the load is applied and to continue to crank while being
provided with vigorous verbal encouragement throughout each sprint. The Wingate protocol
consisted of a total of five 30 sec sprints with approximately 4 min recovery (i.e., very slow
unloaded pedaling), while those completing the Tabata protocol were asked to exercise for a total of
5 min, sprinting for 20 sec and recovering for 10 sec, completing a total of ten sprints in that time.
Table 1 summarizes the two sprint protocols.
Peak and mean power (W), as well as total work (kJ) were measured and stored using the
SRM power meter and downloaded for later analysis using commercially available software
(Training Peaks 3.0, Training Peaks, Boulder, CO). Blood lactate samples (5 µl) were measured from
the fingertip using a small plastic lancet prior to exercise, immediately following, 1 min and 3 min
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after exercise, and analyzed using a Lactate Scout Analyzer (EKF diagnostic sales GmbH,
Barleben/Magdeburg). Each sprint session lasted between 15 and 30 min with warm-up.
Blood Analysis
Hemoglobin concentration (g·dL-1) and hematocrit (%) - using the micro-hematocrit method,
were measured in duplicate and then used to estimate percentage changes in PV (Dill and Costill
1974). An indwelling venous catheter was inserted to allow for convenient blood draws. Blood
samples (~10 ml) were collected together using gray top sodium fluoride tubes (OGTT) and gold top
serum-separator tubes (cytokines) throughout testing and then centrifuged after each session at 4000
rpm for 15 minutes at 4oC. Separated plasma was immediately removed and stored in capped 1.5 mL
polypropylene tubes frozen at -80oC until later analysis.
Oral Glucose Tolerance Tests
OGTT were completed following insertion of a catheter. Blood (~10 ml) was drawn before,
as well as 30, 60, 90 and 120 min after ingestion of a 75% Glucola drink (Fisher Science Inc.,
Philadelphia, PA). Plasma glucose concentrations (mg.dl-1) were measured using the auto-analyzer
glucose oxidase method, while plasma insulin concentrations (mU.L-1) were determined by ELISA
(R&D Systems, Inc, Minneapolis, MN).
Inflammatory Markers
Inflammatory markers of interest included IL-6 (IL-6 B), IL-10 (IL-10 B), and TNF-α
(TNF-α B) measured during baseline testing periods, as well as following each bout of SIT. At
baseline, samples were analyzed from the blood taken at minute 0. On SIT days, 10 ml of blood was
taken prior to, immediately following exercise (P) and 1 hr later (P 1). A final cytokine measurement
was taken prior to the OGTT ~24 hrs after the SIT bout (P 24). Plasma concentrations of IL- 6, IL10, and TNF-α were determined using interleukin-specific Humakine ELISA kits (R&D Systems,
Minneapolis, MN), each completed according to manufacturer’s instructions.
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Coefficients of variation (CV) for baseline Cederholm insulin sensitivity measures was 4.8%,
while IL-6, IL-10, and TNF-α were 9.9%, 6.1%, and 6.6%, respectively.
Statistical Analysis
Data were analyzed using commercially available software (Jump 13.0, SAS Institute Inc,
Cary, NC). All data are presented as means ± SE. Area under the curve (AUC) was calculated using
the trapezoidal rule, while the Cederholm index, which represents peripheral insulin sensitivity, was
calculated using the formula:
Cederholm Si = 75000 + (G0-G120) × 1.15 × 180 × 0.19 × BW/120 × Gmean × log (Imean)
1000

BW = body weight, G0 and G120 are plasma glucose concentration at 0 and 120 min (mmol·l-1), and
Imean and Gmean are the mean insulin (mU·l-1) and glucose (mmol·l-1) concentrations during the OGTT.

All exercise responses were analyzed using repeated measures ANOVA with post hoc Tukey
tests. A 2X2 model was used to assess pre to post exercise response to the OGTT, including AUC
and Si. Dependent t-tests were run to compare change in Si following Tabata and Wingate SIT from
baseline and at 24-hr. A 2 X 4 model was used to determine the effect of SIT on IL-6, IL-10, and
TNF-α. Finally, Pearson’s correlation coefficients were calculated to examine the relationships
between Si and changes in cytokine response.
RESULTS
Fifteen subjects completed both sprints sessions, with one subject unable to complete 24 hr
follow-up after the wingate session due to inclement weather. Subjects were 23.8 (+0.9) yrs old,
180.0 (+2.7) cm tall, weighed 78.5 (1.6) kg, were 16.9 (+1.7) % body fat, with a mean VO2 Peak of
42.0 (+2.0) ml.kg-1.min-1 at 237.0 (+14.6) W. Dietary analysis indicated our participants consumed a
diet consisting of 2077.5 + 132.3 kcal from 81.9 + 8.0 g of fat, 243.2 + 14.4 g of carbohydrate, and
93.2 + 6.8 g of protein. Table 1 provides a summary comparison of SIT session variables. Of specific
note, the percentage of VO2Peak power was significantly higher (p < 0.001) during WIN (196.8 +
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4.2%) compared to TAB (95.6 + 4.2%); . However, there were no differences in total kJ expenditure
(p = 0.5152) or blood lactate (p = 0.8307) between SIT sessions.
Insulin Sensitivity (Si)
Baseline Si for all subjects was 75.9 (+ 1.0) mg.I2.mM-1.mU-1.min-1. Table 1 summarizes pre
and post OGTT data for both SIT sessions using an intent-to-treat analysis. As noted above, one
subject was unable to complete 24 hr post testing, including OGTT, after WIN training. These data
indicate that Si was significantly reduced (p = 0.031) after WIN (n=14), while Si after TAB was
consistently (n=12 of 15), though not significantly lower (p = 0.144). There were no differences
between sprint sessions (p = 0.6723) and AUC for neither glucose nor insulin were significantly
impacted (see Table 1).
Inflammatory Cytokine Response
Plasma cytokine levels of IL-6, IL-10 and TNF-α were measured in all 15 subjects during pre
OGTT (baseline), and TAB test sessions, however, only 14 subjects of 15 subjects were measured 24
hrs after WIN. Overall findings showed that both TAB and WIN lead to significant increases in IL10 and TNF-α, but not IL-6 (see Figure 2). IL-10 (Figure 1 B) increased significantly immediately
following TAB (p < 0.0001) and WIN (p < 0.0001), returning to baseline within 1-hr. Similarly,
TNF-α (Figure 1 C) increased significantly immediately following TAB (p = 0.0118) and WIN (p =
0.0118), followed by a significant drop after both TAB (p=0.0013) and WIN (p=0.0077). All
cytokines returned to baseline levels 24-hr after exercise. Results of all significant Pearson
correlations are summarized in table 2. There was a strong inverse relationship between Si B and IL6 B (r= -0.65, p=0.0090). There was, however, no relationship between cytokine increases after
exercise and and Si 24-hr after exercise. While IL-6 was not related to either IL-10 or TNF- α, IL-10
and TNF-α were positively related (r=0.71, p<0.001) .
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DISCUSSION
The purpose of this study was to compare how W:R influences insulin sensitivity (Si) and
inflammatory responses following a single bout of SIT. When matched for energy expenditure, SIT
using brief rest periods (TAB) was expected to elicit an improvement in Si, partly due to a larger
cytokine response. Furthermore, the improvement in Si would be proportional to cytokine release.
However, these data indicate that neither SIT protocol improved Si 24-hr after exercise; Si actually
decreased significantly following WIN. While both protocols significantly increased IL-10 and TNFα concentrations immediately following exercise, IL-6 did not change significantly. Finally, there
was no significant relationship between any of the measured cytokines and Si P 24, but there was a
strong positive relationship between TNF-α and IL-10.
SIT and Insulin Sensitivity
A major finding of this research was that neither TAB nor WIN SIT improved Si P 24,
indicating that W:R does not influence Si in healthy young adults. In the present study, insulin
sensitivity was actually significantly decreased by 5% following WIN, while 5 min of TAB
decreased Si, albeit non-significantly, by 3.6% 24-hr after exercise. This finding was consistent
among subjects in both SIT trials, with only 3 of 15 subjects actually improving Si following TAB.
Close examination of these data show that 2 of 14 subjects had 15% or greater decrease in Si
following WIN. Interestingly, the subject with the largest decrease in Si, ~15% following TAB and
20% following WIN, also had the highest body fat at 24.8%. However, no other differences,
including diet, were noted between subjects, and removal of these outliers did not reverse the trend
towards reduced Si.
The lack of improvement following TAB was unexpected because kJ expenditure was similar
to that of the extended sprint reported by Whyte et al. (2013). There, Si improved significantly 24-hr
after exercise, while WIN SIT did not improve in that study, or others (Brestoff et al. 2010, Richards
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et al. 2010). These researchers suggested that the key factor for acute improvements in Si may be
ATP turnover (Thyfault 2008), which would be maximal during the ~200 sec continuous time trial
used in their study. It was this premise that influenced our choice of the Tabata SIT intervention. As
reported by Tabata et al. (1997), 4 min of the 20 sec work to 10 sec rest ratio maximally stimulated
oxygen consumption and anaerobic capacity; peak VO2 in the final 10 sec of the 4 min Tabata was
similar to their subjects’ VO2

max,

as was the accumulated O2 deficit. In order to match kJ

expenditure in our study, our TAB SIT session lasted an additional 50 sec (i.e., two 20 sec sprints),
with a total duration exceeding Whyte’s extended sprint, and likely maximally stimulating
mitochondrial ATP production. Therefore, kJ expenditure and ATP turn-over may not be critical
factors at play. Of particular note, however, Whyte et al. (2013) enrolled overweight and obese male
subjects, while we studied healthy young adults, who were relatively lean (body fat % = 16.9).
Nonetheless, the outlier showing the greatest drop in Si following TAB also had the highest body fat
at nearly 25%. Therefore, it appears that changes in Si following a single session of SIT are complex
and warrant further investigation.
SIT impact on the inflammatory response
A second important finding of this study was that W:R does not differentially effect
inflammatory cytokine release following SIT. In addition, we noted that IL-10 release is not
dependent on IL-6, but that increases in IL-10 immediately following SIT are directly proportional to
TNF-α (r=0.71, p<0.001). To our knowledge, this is the first study to show such a response
following exercise. For example, prior research by Meckel et al. (2011, 2009) and Nemet et al.
(2009) reported that running sprint exercise significantly increased IL-6 1-hr after exercise, but does
not influence IL-10 (Nemet et al. 2009) in trained men and women. In contrast, Brestoff et al.
showed that a session of five Wingate sprints (1:9 W:R) did not alter IL-6 or TNF-α release after
exercise in recreationally active men and women. In the present study, SIT using a disparate W:R
produced a similar inflammatory response (Figure 2) that contrasted changes seen during endurance
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exercise. Specifically, endurance exercise is viewed as anti-inflammatory on balance, with a large
increase in IL-6 immediately following exercise, followed later by IL-10, and little if any change in
TNF-α (Febbraio and Pedersen 2002). The combined increase in IL6 and subsequently IL-10 have
been implicated in the improvement in Si following exercise (Pedersen 2001; Steensburg et al. 2003),
however, direct evidence for this is absent from the literature.
A major premise of cytokine release following endurance exercise is that IL-6 is released
directly from the muscle, making it a myokine (Pedersen 2011), and that this release from the muscle
influences its anti-inflammatory role. Further, IL-6 is believed to be a stimulant to IL-10 release,
which is a known inhibitor of TNF-α (Dhingra et al. 2009; Steensburg et al. 2003; Armstrong et al.
1996). The current study suggests that SIT, regardless of W:R produces a more pro-inflammtory
response, with nearly a 60% increase in TNF-α immediately following exercise, as well as a similar
increase in IL-10. This finding is important for two reasons. First, it shows that IL-10 can increase
following intense exercise independent of IL-6, and second, it suggests that IL-10 may increase in
response to TNF-α. The latter is supported indirectly by the fact that both IL-10 and TNF-α increased
significantly immediately following both SIT sessions, followed by a significant decrease in TNF-α
1-hr after exercise, and that IL-10 levels were strongly related (r=0.87) to TNF-α immediately
following both SIT sessions. As indicated, IL-10 is a potent mediator of TNF-α (Dhingra et al. 2009;
Armstrong et al. 1996), and may have little influence on Si following SIT. This pro-inflammatory
response, though transient, may be an important stimulus for long-term adaptation, much like
transient increases in cortisol and growth hormone are to muscle remodelling (Häkkinen and
Pakarinen 1993), or reactive oxygen species (ROS), like H2O2, and lactate accumulation are to
mitochondrial biogenesis (Lira et al. 2010; Hashimoto et al. 2007).
SIT: Inflammation and Glucose Regulation
Presently our understanding of cytokine release following exercise is largely based on
endurance exercise studies, which propose that anti-inflammatory cytokines contribute to an acute
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improvement in Si (Pedersen 2011, Brandt and Pedersen 2010, Petersen and Pedersen 2006;
Steensberg et al. 2003, Febbraio and Pedersen 2002), as outlined in Figure 3. Our data indicate that
SIT does not have an acute impact on IL-6 release, nor does acute SIT influence on Si, regardless of
W:R. Additionally, there was no relationship between cytokine release and Si, suggesting that
inflammatory cytokines do not play a significant role in the improved Si seen in SIT studies of at
least 2-wk (Trilk et al. 2011, Richards et al. 2010, Whyte et al. 2010, Babraj et al. 2009). Therefore,
similar to studies examining endurance performance following SIT (Laursen 2010; Burgomaster et
al. 2008), metabolic improvements after SIT may follow a different set of cellular pathways than
endurance training. For example, Coffey and Hawley (2007) outlined four distinct signals for
mitochondrial biogenesis and improved glucose regulation, including mechanical stretch, increased
intramuscular calcium concentration, reduced muscle ATP concentrations, and an increase in ROS,
or other disruptions to muscle homeostasis. While all of these are likely involved in SIT adaptations,
the last would support the role of inflammatory cytokines in this process; however, far more work is
needed before direct conclusions can be drawn.
The results presented here are a preliminary attempt to elucidate the inflammatory response
following SIT and its possible role in the chronic training improvements reported from a variety of
sprint protocols. These data, while intriguing, are based on a relatively healthy population of college
age adults. The fact that these data seem to contrast those of Meckel et al. (2011, 2009), who studied
sprint training in elite athletes, indicates that population characteristics and fitness level likely
influence inflammatory and metabolic responses to SIT. The results in the present investigation
demonstrate the need for examining a number of mechanisms in various populations to better
understand the possible health benefits of SIT.
In conclusion, sprint interval work to rest ratio has no apparent impact on insulin sensitivity
or inflammatory responses 24-hr after training in healthy young males. It would appear that repeated
bouts of SIT over at least 2 weeks are needed to improve insulin sensitivity. These data indicate that
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the inflammatory response following SIT is very different from that of endurance training, which
indicates a largely anti-inflammatory effect. SIT failed to produce a significant increase in IL-6
release, but instead showed a strong response from TNF-α and IL-10, which both peaked rapidly
after exercise and returned to baseline within 1-hr. It would appear that following SIT, the latter two
cytokines follow a release pattern more similar to that seen during sepsis (Fischer et al. 2006;
Dhingra et al. 2009; Armstrong et al. 1996) than endurance training. In this sense, SIT may be
considered pro-inflammatory. It is not known whether this seemingly pro-inflammatory response
serves as a stimulus for positive adaptation.
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Tables and Figures
Table 1. Comparison of Tabata and Wingate protocols and exercise session data, including pre and
post OGTT data. Data are presented as means (+ SE). Note, only 14 of 15 subjects completed
Wingate SIT. * Denotes significance.

Workload

Tabata

Wingate

5

7

10

5

20/10

30/270

2:1

1:9

(% Body Mass)

# of Sprints
Work/Recovery
(sec)

W:R

P-value
Pre-Post

P-value
Between
Sessions

Mean Power (W)

223.2 (17.1)*

457.8 (17.1)*

N/A

< 0.0001

% VO2 Peak Power

95.6 (4.7)*

196.8 (4.7)*

N/A

< 0.0001

Energy (kJ)

64.7 (3.5)

68.0 (3.5)

N/A

0.515

BLC (mM)

12.8 (0.7)

12.6 (0.7)

N/A

0.831

HR (bpm)

180.7 (2.4)

173.9 (2.4)

N/A

0.054

TAB 0.144

0.672

OGTT Data
Si – Cederholm
(Mg*I2*mM-1*mU-1*min-1)
Pre-training
Post-training

75.9 (1.0)
73.2 (1.0)

72.1 (1.0)*

WIN 0.031*
Glucose AUC
Pre-training
Post-training

444.1 (17.99)
426.3 (17.99)

429.3 (18.63)

TAB 0.766

0.993

WIN 0.836
Insulin AUC
Pre-training
Post-training

91.9 (14.47)
79.5 (14.47)

87.2 (14.98)

TAB 0.818
WIN 0.927
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0.973

Table 2. Summary of significant Pearson correlation coefficients. No other significant relationships
were observed. Note, B= baseline; P = immediately post exercise; P24 = 24 hr post exercise.
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Independent Variable!

Dependant Variable!

r!

IL-6!

S i!

r= 0.24!

0.0364!

IL-6 B!

S i!

r= - 0.65!

0.0090!

TNF-α!

IL-10!

r= 0.71!

<0.0001!

Tabata!

!

!

!

TNF-α P!

IL-10!

r= 0.87!

0.0025!

TNF-α P24!

IL-10!

r= 0.76!

<0.0475!

Wingate!

!

!

!

TNF-α P!

IL-10!

r= 0.87!

0.0021!
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p-value!

Figure 1. Graphic summary of the experimental design for the study. Note: OGTT=oral glucose
tolerance test; SIT=sprint interval training; TAB=Tabata short recovery exercise; WIN=Wingate
long recovery exercise.
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Figure 2. The effect of sprint interval training on IL-6 (A), IL-10 (B), and TNF-α (C). IL-10
!
increased significantly immediately following Tabata (p<0.0001) and Wingate (p<0.0001).
Similarly, TNF-α increased significantly following Tabata (p=0.0118) and Wingate (p<0.0118),
then dropped sharply 1 hr after exercise (p=0.0013 and p=0.0077, respectively). * Denotes
significance from prior time period.!
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!

Figure 3. Schematic summary of the initiation of muscle-derived IL-6 release and the subsequent
role that IL-6 plays in various organs that lead to enhanced glucose uptake. IL-6 promotes GLUT4 activation in the brain, liver, and even skeletal muscle, as well as promoting IL-10 production.
IL-10 blocks TNF-α and macrophage constituents, which interfere with GLUT-4 (Adapted from
Febbraio and Pedersen 2002; Pedersen and Fischer 2007).
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CHAPTER 4
DISSERTATION CONCLUSIONS
Historically, physical activity and health researchers have focused on the benefits of aerobic
endurance activity. More recently, investigators have sought to examine alternative forms of physical
activity, including HIT.The revelations regarding low volume, high-intensity interval exercise,
including sprint interval training, represent a major paradigm shift in our perspective on optimal, as
well as, minimal exercise prescription requirements. Further examination of HIT, and specifically
SIT, will enhance our understanding of the underlying mechanisms related to both acute and chronic
adaptive processes. In the two studies presented here, SIT was studied over the course of 2-wk in
persons with spinal cord injury, as well as for a single session among healthy adults. While these
studies yielded mixed results, our findings provided important information regarding applications for
SIT and future research.
Among persons with SCI, 2-wk of SIT failed to alter the profound disruption of glucose
metabolism within this population. However, we were able to demonstrate a significant reduction in
blood lipids (NEFA) linked to insulin resistance. Subjects in this study tolerated training well,
indicating that additional SIT research is needed on optimal application of SIT for non-ambulatory
populations, including persons with SCI. Furthermore, it is unclear whether the improvement
threshold for upper extremity SIT differs from lower extremity, further supporting the notion that far
more research is needed on the application of high intensity training for all special populations.
As a follow-up study, we explored the role that W:R plays on the acute SIT effects on
metabolic and inflammatory responses. Research in this area has been sparse and inconclusive, with
some researchers (Meckel et al. 2011, 2009) indicating that SIT increases acute (pro) inflammation.
Our findings indicate that sprint interval inflammatory response is similar for disparate W:R.
Additionally, neither insulin sensitivity nor inflammatory responses differ between W:R protocols
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24-hr after exercise. It appears that at least 2 weeks of SIT are needed to improve insulin sensitivity.
Based on the available data, the inflammatory response following SIT differs from endurance
training, and could be considered pro-inflammatory. More research is needed to elucidate whether
the inflammatory responses seen in our research plays a significant role in the long-term adaptation
to sprint training.
Future Directions
Taken together, the research presented here indicates that far more research is needed to
understand the acute impact of SIT on both the metabolic and inflammatory responses among
different populations. It is unclear how individual physiology among various special populations
may impact the adaptive processes of training. In addition, more research is needed to expound on
whether or not, and if so how the post-SIT inflammatory response influences metabolic and
performance adaptations. Data here and elsewhere indicate that SIT has many more revelations to
reveal in the years to come.
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APPENDICES
Appendix A. Review of Literature
Spinal cord injury and sprint interval training
Recent statistics indicate that there are approximately spinal cord disorders and injuries is
close to 6 million Americans2, which accounts for nearly 2% of the U.S. population. While difficult
to fathom, the true costs spinal cord injuries (SCI) are far greater to the overall quality of life of those
with SCI who face a milieu of health and daily activity problems, as well as staggering care costs;
lifetime costs range from $800,000 to over $5 million for patients in their mid-20’s2,3. Of significant
concern is the prevalence of metabolic syndrome (MtS) among SCI patients secondary to obesity4-8,
which no doubt contributes significantly to the cost of care in SCI. Because of the close relationship
between MtS both obesity and blood sugar management, addressing either or both of these must be a
priority in treating MtS among SCI. Individuals with SCI, however, have little influence over their
development of CVD, obesity or MtS, making management seemingly insurmountable.
Exercise is a useful tool in the reduction of body fat9 and an effective means for improving or
reversing many of the constituents of metabolic syndrome, including glucose effectiveness and
insulin sensitivity10-13. Yet, fewer than 50% of American’s meet current ACSM recommendations for
physical activity14 – recognize that ACSM recommendations are for risk factor reduction, not weight
loss. Unfortunately, if able-bodied obese individuals find exercise a daunting task, the person with
SCI may find exercise frustrating and limited at best, and nearly impossible at worst due to physical
and physiological limitations of the injury. Nonetheless, exercise must remain an important
component to managing risk factors and enhancing SCI quality of life. Greater understanding of the
acute and chronic exercise training responses are needed in SCI, with emphasis on modalities
focused on improving overall functionality for SCI and metabolic improvement. Therefore, the
purpose of this review is to summarize the literature on spinal cord injury health consequences,
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contemporary exercise research on available modalities, and potential applications of emerging ablebodied training research.
Spinal Cord Injury in the U.S.: Demographics
Spinal cord injury accounts for nearly a quarter of all paralysis in the U.S., with more than
half of those injuries caused by some type of accident (see Figure 1 for details) and nearly equal
representation among men and women. While 80% of all persons are considered “White”, evidence
suggests that SCI may be disproportionately represented among minority groups. The average age
for SCI is 52 years with the average time since injury approximately 16 years with more than a third
of SCI under the age of 402, indicating that many individuals have the potential for a long life of care
post injury (Table 1). Not surprisingly, as post-injury life expectancy increases so does cost of care.
Current estimates lifetime costs vary among different cohort groups3,15-17, and can range from more
than $800,000 to over $5.4 million for patients in their mid-20’s3,15-17
The breadth of these estimates reflects the range of injury severity and care needs among
SCI. For example, the single year cost for a cervical level complete (i.e., no motor function below
the injury level) can be as much as five times higher than those for an individual with an incomplete
lumbar injury16. In the first year alone, cost of care averages more than $520,000, and can be as high
as $1,000,000. These costs burden both the medical system, as well as for the individual, both of
which influence quality of care. Consider that the U.S. Census Bureau indicates that the 2009
Median household income was $49,777, while 80.1% of SCI report an income of less than $50,000.
In fact, at least half of all SCI live below federal standards for poverty ($22,350). New data suggest
that the impact of SCI on income is closely linked to employment following injury. For example,
individuals with SCI show a $25,000 drop in income on average, which is directly attributed to a
70% increase in unemployment following injury.18 Thus, it is possible for SCI to quickly move an
individual from the median to poverty. One cannot overlook the link between MtS, and any of its
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components, particularly obesity, and poverty19. Whether or not the latter issue can be addressed, it
must be acknowledged when trying to exact health improvements among SCI and reduce MtS.
Metabolic Syndrome and SCI
Cardiovascular disease (CVD) remains the leading cause of death in the United States,
accounting for more than 27% of the reported deaths in 200520. The staggering toll heart disease
plays within healthcare often overshadows the complex interaction of underlying factors typically
referred to as the metabolic syndrome21. Despite a clear consensus on the definition or clinical
diagnosis of MtS among leading organizations (see Table 2 for a comparison), the overlap is
considerable and includes obesity, poor glucose regulation/insulin resistance, hypertension,
dyslipidemia (e.g., high triglycerides or low HDL)22, with cardiovascular disease (CVD) recognized
as a major outcome. Additional factors suggested by the Adult treatment Panel III (ATPIII) report
also include increased systemic inflammation, typically marked by elevated C-reactive protein levels
(CRP) and a prothrombotic environment, characterized by elevated plasminogen activator inhibitor
(PAI)-122,23. The latter two are often ignored in the clinical assessment of MtS due to the difficulty
and cost of measuring them and their close relationship to obesity; both CRP and PAI-1 are
synthesized by adipose tissue, so as body fat increases, so do CRP and PAI-1. In fact, the exact role
obesity plays in development of CVD or other components of MtS, most notably insulin resistance,
is nearly impossible to assess because of the intricate relationship obesity has with each component.
For example, obesity is known to cause insulin resistance through a cascade of interactions, while
insulin resistance often exacerbates obesity23. Taken together, one can understand how obesity alone
plays a multi-factorial role in MtS and supports the premise that obesity may precede MtS24.
Moreover, MtS is strongly related to the development of diabetes and CVD25, both of which show
increased prevalence among SCI. However, the relationship between MtS and SCI is not quite so
clear.
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Compared with able-bodied individuals, those with SCI exhibit increased rates of obesity26-28,
hypertension26-28, insulin resistance or diabetes7,8,25,29,30, systemic inflammation4,6, and ultimately
CVD31-33. Yet, the individual prevalence of MtS among SCI does not appear higher than ablebodied25, which on the surface might seem counter intuitive until one examines the data closely and
suggests that certain components of MtS may have a greater impact on the development of CVD
among SCI and should be examined accordingly. Chief among these is obesity, which, based on its
complex interaction within the body has multifarious outcomes.
Obesity and SCI
It is now believed that more than one third of the U.S. adult population is obese34, which may
be far less than SCI obesity rates26-28. Sources vary widely, however, with data by Weaver et al.26
indicating that 31% of SCI veterans were classified as obese, while Rajan et al.27 reported that as
many 66% of SCI are obese. One reason for the disparity may be the use of BMI, which grossly
underestimates body fat in this population7,26. Disregarding BMI data are difficult, due to their
ubiquity, but dual x-ray absorptiometry (DXA) data by Spungen et al.28 supports these numbers and
that age has a significant impact on body fat; individuals over the age of 40 have significantly more
body fat than those under 40. Unfortunately, a clear understanding of body composition and
metabolic syndrome among SCI are still not entirely clear, with a reassessment and adjustment of
current body composition methodologies. Nonetheless, increased body fat is a trademark for SCI,
with the typical new SCI gaining nearly 14 kg of fat in the first two years of injury35. Thus,
addressing MtS among SCI cannot be separated from addressing the increase in body fat because in
addition to the obesity-MtS link, increased fat mass will promote insulin resistance and hypertension,
and further limit functional ability to complete either exercise or activities of daily living (ADL), as
well as encourage dyslipidemia (Figure 2)1.
Disordered Carbohydrate Metabolism
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There are many indications that SCI do not metabolize and regulate carbohydrate as
effectively as able-bodied1,8,29,30,32. For example, early research often relied on small sample sizes
making definitive conclusions difficult, while recent data have shown that more than a third and as
many as two-thirds of SCI may exhibit impaired fasting glucose

1,32

, while those exhibiting frank

diabetes ranges from 15 – 22%29,30,36, which is three-fold higher than the general population. As is
seen in many instances among SCI, level and completeness of injury influences carbohydrate
metabolism (e.g., complete tetras fair worse than other SCI), as does age

1,32

; age related increases

may ultimately relate to continued increases in fat mass, as demonstrated in the general population37.
However, the underlying mechanisms for the development of metabolic disorders in SCI have not
been fully elucidated. For example, as depicted in Figure 1, SCI appears to promote insulin
resistance and pancreatic/β cell by itself, as well as in conjunction with the reduction in activity,
development of obesity, loss of muscle mass, and inherent changes in the paralyzed muscle38,39
which may by itself alter carbohydrate metabolism40. Therefore, all the potential factors influencing
development of carbohydrate disorders in SCI should be considered.
Adipose tissue, no longer considered inert tissue, is involved in the modulation of the
metabolic function in the body by releasing non-esterified fatty acids (NEFAs), hormones, and as
previously mentioned, CRP, all of which have a unique impact on insulin resistance and are all
believed to be elevated by obesity41. Of those above, NEFAs may be the single most important factor
for altering insulin sensitivity, with insulin resistance developing within hours of NEFA infusion 41.
Normally associated with fasting, obese individuals release excess amounts of NEFAs despite higher
insulin levels, which should actually suppress lipolysis. The influx of NEFAs into the muscles
further enhance insulin resistance, possibly by increasing muscle fatty acid metabolites, like
diacylglycerol, which in turn inhibit insulin signaling, as well as interfering with the insulin receptors
which are involved in the activation of glucose transporter isoform 1 (GLUT-1) and GLUT-423,41-43.
While the exact mechanisms are poorly understood, NEFAs also appear to interfere with the
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compensatory feedback loop for insulin secretion, and act synergistically with elevated glucose to
have a glucolypotoxic effect on β cells41.
SCI fill a unique niche here, because they can develop insulin resistance and obesity
separately. Worse still, the disruption or cessation of the autonomic nervous system in SCI can
further exacerbate pancreatic/β cell function by disrupting normal insulin release41, which could
partly explain the rapid development of insulin resistance in SCI. Additionally, peripheral changes in
the paralyzed muscle may also impact carbohydrate metabolism disorders.
Following SCI, it is difficult to point to one single change or event that ultimately influences
metabolic function. One often does not consider, or perhaps cannot fathom the minute control the
central nervous system (CNS) exhibits over the entire body, including maintenance of the tight
control of the organs, or the role of muscle tone and hence mass. Chronic SCI is far more than loss of
walking ability; it can mean the loss of nearly half the metabolic “engine” and glucose repository,
namely the lower extremity musculature. The loss of muscle and increase in fat seems to occur as
readily, though to a lesser magnitude among incomplete injuries as it does in completes39, greatly
limiting the metabolic role that leg muscle plays in glucose metabolism. Following injury there is a
preferential atrophy of Type II fibers, followed by Type I fibers with a continual infiltration of
intramuscular fat in just the first three months. as an injury persists, muscle fiber conversion takes
place. While the precise time line (e.g., < 6 mo vs. > 6 mo) is still unclear, data indicate that muscles
atrophy and shift to a fiber-type composition made up of mostly Type IIx fibers38,39,44, with only rare
exceptions escaping this fate45. Again, such changes seem mundane on the surface, but may play a
larger role in the overall life of SCI.
Higashiura et al.40, demonstrated the postive linear relationship between Type I fibers and
insulin sensitivity, and the negative linear relationship between Type II muscle fibers and insulin
sensitivity. In conjunction with the sweeping changes seen in SCI, fiber conversion more likely
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limits lower body training effectiveness, but could exacerbate insulin resistance in SCI46-48. Thus, it
is not surprising that SCI have a different risk pattern for MtS than the able-bodied25.
Hypertension in SCI: Still a silent killer
Hypertension has long been termed the “silent killer” in the United States and has a profound
influence on the development of CVD (Grundy 04). Nearly two-thirds of the population develops
hypertension by age 6049, with the prevalence of HBP among obese individuals six times higher than
normal weight individuals50. The prevalence among SCI is believed to be much higher1,8,26. For
example, a recent report by Weaver et al.26, indicates that nearly 60% of SCI may be at least
borderline hypertensive, with nearly half those considered hypertensive. Worse still, diabetic SCI are
more than twice as likely to be hypertensive1. Again, the inter-relationships between obesity,
diabetes and hypertension is extremely complex, but the role that proinflammatory elements like
CRP, released by adipose tissue, have on vascular function are important to recognize when working
with SCI. Further, the role that autonomic dysfunction, including baroreflex dysfunction, among SCI
further complicates systemic blood pressure (BP) control at rest and during exercise by limiting the
hemodynamic response and predisposing SCI to uncontrolled shifts in BP. Of the range of
abnormalities, the most dangerous is autonomic dysreflexia (AD)8,33.
Characterized by hyper responsive sympathetic outflow in response to a noxious stimuli (e.g.,
distended bladder, cut or fracture, burn) below the SCI, AD should be considered dangerous, or lifethreatening, and requires immediate treatment51. Fairly common in SCI of Thoracic level six or
above, uncontrolled AD can limit one’s ability to safely perform activity or exercise training.
Moreover, sharp fluxuations in blood pressure will have obvious detrimental effects on health,
including cerebral vascular events. Nonetheless, AD and hypertension are two distinct conditions,
where AD is mediated by SCI, while hypertension is strongly influenced by the development obesity
following SCI.
Dyslipidemia and Cardiovascular Disease
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Ultimately, the impact of MtS on any population is typically an increased risk for developing
CVD. While commonsense suggests that SCI should have a much higher prevalence of CVD than
able-bodied individuals, the literature indicates this may not be the case. For example, Myers et al.33
reported a much higher prevalence of CVD among SCI than ambulating populations, suggesting that
paraplegics (para) have a 70% greater risk for CVD and that 65% of para’s suffer from “silent
ischemia”. However, in a far reaching review, Wilt et al.1 unraveled much of the confusion
surrounding CVD in SCI and support the suppositions of Liang et al.25 that the absolute risk of
specific factors varies between SCI and able-bodied. In fact, it appears that two overwhelming
factors influence CVD development among SCI, dysfunctional carbohydrate metabolism and
obesity.
One cannot overlook the impact of blood lipid disorders in SCI, particularly increased LDL
cholesterol (LDL), and extremely low HDL cholesterol (HDL).25,32,33 For example, Bauman and
Spungen (2008) reported that as many 40% of SCI have an HDL less than 35 mg/dL, compared with
10% in the general population, and that HDL was inversely related to triglyceride levels.
Interestingly, both obesity and low HDL were found to be the only significant risk factors for
developing MtS in SCI25, while the relative risk for developing CVD may be similar between SCI
and able-bodied1. The former observation is interesting when one considers that obesity increases
NEFAs, and NEFA levels play a significant role in modulating blood lipids.43,52
Pro-inflammatory Environment: The final denominator
Of all the factors influencing MtS, systemic inflammation component is increasingly seen as
the missing link between MtS and atherogenesis53. The interrelationship between obesity and this
subclinical inflammation relates to adipose tissue’s release of inflammatory molecules like CRP,
tumor necrosis factor (TNF)-α, IL-1, and IL-6, which also interfere with insulin action53. The
interelationship between obesity and insulin resistance is further muddled after spinal cord injury.
For example, IL-1, IL-6 and TNF-α rapidly increase within hours after SCI but may serve both an
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inflammatory and neurotrophic response54,55. Further, chronic SCI have been shown to exhibit
subclinical inflammation7,8,56 which may be involved in a proregenerative response in SCI56.
Nonetheless, the proinflammatory cyctokine linkage to MtS and the high rates of MtS among SCI,
may necessitate controlling this response to alter the prevalence of MtS in SCI.
Exercise as Medicine
It could be said that exercise is an effective treatment for many of modern society’s ills. As
with any drug, it has risks associated with it, but probably carries far greater benefits than negative
side effects. Yet, exercise remains an underutilized component of disease treatment. For the SCI
patient, exercise may be the most important treatment to maintain long-term health and
independence. The prevalence of MtS among SCI demands a potent treatment of some of the major
constituents like diabetes and hypertension. In a brief review, Colberg and Grieco11 discussed the
central role physical activity can and should play in both the prevention and treatment of diabetes. Of
particular importance are the increases in glycogen synthase in response to aerobic training, while
GLUT4 expression has been shown to increase following both aerobic11 and resistance training57. In
addition, resistance training (RT) increases muscle mass, allowing for a larger repository for glucose
uptake. Further, improvement in insulin resistance and/or type 2 diabetes is independent of weight
loss, because exercise decreases both visceral and intramuscular fat, both of which exacerbate insulin
resistance58. Most intriguing, however, is the role that intensity may play in reversing many of the
components of MtS.
It has also been proposed that the degree of mitochondrial biogenesis can have an impact on
managing, or even reversing insulin sensitivity and the progression of diabetes12. Due to the link
between improved mitochondrial biogenesis and function with GLUT4 expression, Earnest12 has
hypothesized that high intensity interval training (HIT) provides a more powerful stimulus
improving insulin sensitivity than traditional moderate aerobic exercise related specifically to the
metabolic processes (e.g., aerobic glycolysis, beta oxidation, and mitochondrial biogenesis). The
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efficacy for high intensity training has been shown in a variety of populations13,59-69, which has been
shown to reverse heart disease cardiac damage69, promote insulin sensitivity, and perhaps reverse
diabetes13,70.
In the past decade, research among able-bodied persons using HIT and sprint interval training
(SIT) have shown great promise in not only improving endurance performance to equal or greater
levels than endurance training61-63,65,69,71-82, but also enhancing fat metabolism82, glucose tolerance83
and vascular function68. It comes as little surprise to sports scientists, who have known for years that
peak athletic performance demands maximal intensity exercise. Yet, contemporary exercise advice84
have recommended similar guidelines to the general public for decades. Some of the reluctance has
come from a fear that high intensity intervals were dangerous for high-risk patients (e.g., those with
cardiac disease). As indicated earlier, however, even in post-infarction heart failure patients, exercise
intensities greater than 90% peak heart rate were not only safe, but were also more effective at
improving VO2

peak,

and actually shown to reverse left ventricular remodeling69,85. Some would

argue, however, that high intensity training actually discourages participation and compliance.
However, recent data suggest the opposite. For example, Gibala reported86 that HIT has been
successfully used in a range of populations, including persons with diabetes and MtS, as well as men
and women over the age of 65. Wisloff indicates that many individuals prefer HIT to continuous
training because of the reduced time commitment, and clearly defined session objectives and endpoint.87
Endurance exercise is part of an effective treatment for CVD and obesity. Therefore, HIT
could indeed be a critical factor in reversing the MtS. Perhaps such a statement is bold, but for a
population that has very limited exercise capacity to start with and a high risk for overuse injury of
the shoulder, short, high intensity work bouts may provide a means to mitigate or reverse risk, while
building overall work capacity. Of greatest interest are data from a series of studies from McMaster
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University61-66,68,72,73 indicating that low volume sprint interval training (i.e., 30 sec Wingate Sprints)
yields results comparable to that of traditional submaximal endurance training.
Early work by Dudley et al.88 eloquently showed enhanced endurance performance in
response to increased intensity. Since then, data from both endurance athletes and untrained
individuals have shown that HIT – intervals of 1 – 5 min - are an effective12,69,82 and often necessary
tool for improving exercise performance74-78,81,82,89. Although the metabolic and cardiovascular
response to Wingate sprints seemed to contradict an endurance adaptation, Stepto and Hawley81
showed that among trained cyclists, 30 sec intervals improved 40 km time trial performance as much
as 4 min VO2 max intervals; both were superior to other intervals used. However, this paper stood in
isolation for nearly a decade before data by Burgomaster, Hughes et al.63 and Gibala et al.65 both
indicated that supramaximal Wingate SIT produce similar initial metabolic/biochemical changes in
the trained musculature63 as long-term endurance performance

61,65

as more traditional endurance

training. Subsequent data from these researchers has shown that from a cell signaling perspective,
SIT is more closely related to endurance than strength training, acting as a potent stimulus for PGC1α expression by up regulating AMPK and p38 MAPK signaling pathways72, all of which are closely
tied to endurance adaptation90, including mitochondrial biogenesis80, insulin sensitivity70, and even
fiber type transformation70,91,92. Not surprisingly, improvement in endurance characteristics are
inherently linked to improvement in insulin sensitivity and glucose tolerance, and indeed, this is
what we see following just 2 weeks of SIT training in several populations.83,86,93,94
Questions arise whether such high intensity work is realistic for many individuals. In light of
this, Gibala’s group67 proposed a less taxing training regiment using 1 min intervals at VO2

Peak

wattage followed by 75 sec of recovery completed 8 – 12 times. Total training time was less than 30
min and subjects reported none of adverse effects, like nausea, sometimes reported following SIT.
After 2 weeks (6 sessions total) subjects improved performance about 10%, as well as increased
mitochondrial enzyme content (~35%), markers of biogenesis (~30%), and GLUT4 content (119%),
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putting it on par with endurance and SIT adaptations. Moreover, Gibala has indicated that HIT has
been effective and shown good compliance across many populations.86
Another question that arose from Gibala’s work13, was whether sprint training adaptations
were short lived and represented early adaptations. Two unrelated studies addressed this issue and in
doing so, validated the Overload principal in untrained and trained individuals. For example,
Nordsborg et al.95 compared the molecular response via alterations in mRNA PGC-1α following HIT
in both untrained and trained (1 yr training and VO2

Peak

55 ml.kg-1.min-1) individuals. Trained

participants did HIT sessions at 85% of the untrained VO2 Peak power and 85% of their Peak power.
As expected, training at the same absolute power did not yield any significant changes in the trained
group, while 85% of each group’s max (i.e., same relative power) showed significant increases in
mRNA PGC-1α. Another interesting finding, not surprisingly, were lactate levels for trained
individuals were significantly lower at the same absolute workload. The latter finding brings into
question the role of homeostatic disruption to elicit exercise adaptations, as well as the role of
reactive oxygen species (ROS), like H2O2, and lactate accumulation, implicating both in the upregulation of PGC-1α70,96. Finally, further support for SIT impact on endurance adaptations were
seen in even highly trained cyclists (VO2

peak

~70 ml.kg-1.min-1), who, after completing a single

session of SIT, saw gene expression in several key mitochondrial markers, supporting the notion that
it is the relative intensity of training (i.e., near the individuals “max”) that elicits improvements97.
This relative response may have important training implications for persons with SCI.
To review, high intensity training appears to provide a useful and potentially powerful tool
for endurance and metabolic change in a number of populations. While not entirely clear, it does
appear that the relative intensity and perhaps contribution of motor unit recruitment13,65,72,95,97 may
relate to the underlying mechanisms for these changes. Support for the motor unit recruitment theory
(i.e., activation of high threshold Type IIa/x fibers) is provided first, by lactate data95-97, indicating
that higher blood lactate concentration (BLC) may induce greater PGC-1α mRNA. For example
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expression following exposure to 10 mM lactate, with even further expression after 20 mM
exposure. In actuality, 20 mM increased many hundreds of genes involved metabolism and
mitochondria, several fold more than 10 mM. Further, lactate was shown to activate H2O2
production96, a ROS, another regulator of PGC-1α. How specifically either ROS or lactate influence
this regulation is open to some debate, but ROS are believed to be linked to AMPK’s promotion of
PGC-1α70, while lactate may signal a need for improved oxidative metabolism98, or enhanced lactate
transport into the mitochondria. Moreover, ROS are functionally essential to endurance
adaptations70, and perhaps increased BLC is as well.
Exercise in SCI: Potential vs. Possible
For able-bodied obese individuals, exercise may seem a daunting task that yields mixed
results, while for SCI, the physical and physiologic limitations they endure may minimize exercise
capacity and adaptations outcomes. SCI may exhibit typically display cardiovascular, pulmonary
and/or hemodynamic limitations, sarcopenia, autonomic nervous system and endocrine dysfunction,
lower limb spasticity, diminished bone density, neurogenic bladder and bowel conditions, and risk
for shoulder disabilities8,51,99-105. For example, all SCI patients can expect some limitation on
maximal aerobic power (VO2 peak) simply due to the a smaller available muscle mass and decreased
cardiac preload, secondary to venous pooling; i.e., the engine is smaller and has less available fuel.
However, as the level of the injury increases from T-12 and up, greater overall systemic responses
occur, further exacerbated by the completeness of the spinal lesion or injury (ASI-A or B versus C or
D), and that day to day physical strain during ADL’s is proportional to one’s level of spinal cord
injury106-108. Despite the limitations faced by individuals with SCI and related disorders, exercise
remains an important component to not only managing health risk factors, but also enhancing one’s
quality of life.
Physical limitations
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It has long been held that the key to long life and health was aerobic endurance exercise.
However, training options for persons with SCI are typically limited to either arm crank ergometry,
wheelchair training, or less often, functional electrical stimulation (FES) cycling. Unlike the general
population, however, SCI activities of daily living (ADL) and aerobic fitness are directly tied to
upper body strength107,109. Moreover, as the level of the injury increases from T-12 upward (i.e.,
higher level injury), the greater the strain they suffer. Likewise, individuals may be classified as AIS
A or B, where they have no motor function, or AIS C or D, where motor function is preserved (see
Table 3 for more information).110 Not surprisingly, AIS A and B injuries have greater difficulties
than C or D injuries.107 As individuals with SCI live longer, the risk for shoulder joint dysfunction,
injury and/or degeneration increases. Current estimates among SCI persons indicate that between 30
and 100%99 suffer from shoulder pain at some point in their lives. The cause of such pain can be
diverse and may stem from: poor transfer or pushing technique, incorrectly sized wheelchair,
inappropriate biomenchanics, inadequate strength, acute or injury, chronic overuse, and/or muscular
imbalances between the anterior and posterior musculature. While mild pain may not initially limit
activity, over time, functionality will inevitably diminish. Further complicating those factors is the
presence of paralysis in the upper extremities for tetraplegics.99
Acute Exercise Responses
Acute exercise responses are impacted most by neuroendocrine system, due the nature of the
feedforward and feedback systems in the body and the “fight or flight” response. It is no wonder that
profound cardiopulmonary changes may be seen following SCI, and, like other problems in SCI,
vary by level and completeness of injury. For instance, able-bodied individuals often take for granted
the impact sympathetic drive has on heart rate and heart contractility, which ultimately impact
cardiac output and VO2. For SCI of Thoracic (T) level 6 or lower, this generally is not an issue.
However, loss of sympathetic drive to the heart becomes more likely from T5 upto T1, with a
general loss of cardioacceleration and tone at the cervical level51,103, where maximum heart rate may
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not exceed 100-120 beats. Dela et al.111 confirmed the importance of the ANS in the early increase in
HR for SCI; compared to controls, SCI had a delayed HR increase in response to evoked exercise, as
well as a diminsihed catecholamine response, supporting the role of the endocrine system in
cardioacceleration. Loss of sympathetic drive to the heart will also limit contractility and stroke
volume (SV), explaining part of the decrease in maximal cardiac output. However, decreased venous
return appears to be the major determinant for diminishing submax cardiac output and possible
exaccerbation of cardiovascular drift103,111.
Loss of sympathetic tone on the vessels affects blood pressure and venous return, while the
loss of the muscle pump may severely limit venous return, thereby forcing a compensatory HR drift
in SCI that may not reflect the true intensity of the training session. Circulatory hypokinesis51,112-114
as it has been termed, is common after SCI and results in significant venous statis in the lower
extremities, and has been shown to have a significant deletarious impact on cardiac output during
upper extremity exercise.113 Not unlike an athlete training in a hot environment, individuals with SCI
must contend with cardiovascular drift at every session. Furthermore, diminished venous return and
cardiac output has been shown to limit positive cardiovascular remodelling114,115, which may
diminish the global impacts from arm training and contibute to the difficulty in achieving central
adaptation ins SCI114.
Unlike the cardiac system, separating the role of the central nervous system (CNS) from the
ANS for respiration can be difficult. At rest, the breathing is controlled by the respiratory center in
the medulla oblongata.116, while at the initiation of exercise, motor cortex outflow increases
ventilation rapidly, with rapid feedback from proprioceptive feedback of the active limbs. The spinal
cord, in simplest terms, delivers the information provided by the upper CNS and disruption of the
CNS limits pulmonary function in SCI as low as T11. 117 Somatic or motor function below the level
of injury will lead to a loss of innervation to accessory muscles like the internal intercostals (T1T11), transversus abdominus (T2-L1), obliques (T6-L1), and rectus abdominus (T6-T12), while the
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diaphram is spared dysfunction up to Cervial (C) level 5.8,118 Therefore, pulmonary limitations
become more pronounced as exercise intensity increases; where able-bodied normally are not limited
by maximal pulmonary stress, SCI often will have some breathing limits, in addition to
cardiovascular limits.
Breathing may be further complicated after SCI due to an imbalance the ANS, which controls
sympathetic and parasympathetic outflow to the broncioloes.119 While upper thoracic and cervial
level injury may be largely reliant on the diaphram for breathing, tetraplegics also showed increased
vagal stimulation of the broncioloes, reducing airway caliber and restricting airflow to and from the
lungs. Coupled with diminished chest wall and lung compliance, along with a concomitant increase
in abdominal compliance, tetraplegics have increase in breathing work.120
As already indicated, SCI exhibit lower resting catecholamine levels and a blunted
catecholamine response to exercise that is inverse to the level of injury, with norepinephrine (NE)
being a good measure of sympathetic nervous activity (SNS) and epinephrine (E) a good measure of
adrenal function121. In general, catecholamine deficiency or decreased response is most pronounced
in SCI above T6

111,121,122

. The relative impact of this blunting has clear impacts of cardiovascular

parameters and blood flow, but also metabolic function, and substrate mobilization and utilization,
which may minimize serial impact of training over time (i.e., lower acute leads to reduced chronic
adaptation). E and NE are strong mediators of glycogen breakdown and lactate production, but it is
unclear how closely they are linked to lactate production in persons with SCI.
Frey et al.104 have suggested a parallel relationship between lactate and catecholamines after
SCI where catecholamine deficiency limited maximal blood lactate concentration (BLC). While this
study is often cited as evidence of a blunted lactate response in high level (e.g., above T1) SCI, close
inspection of the available literature104,111,121,123-126 suggests that lactate response in SCI has more to
do with available muscle mass and workload. For instance, Frey et al.104 compared T2 and above
with T10-12 individuals during a progressive arm crank test using 3 min stages. Disregarding the
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small sample size, one obvious finding is the disparity in maximal workload (30 vs. 90 W), which
reflects the difference in upper body strength – a major determinant of arm exercise in SCI

109

–

alone would account for the difference in BLC. While it was also clear that neither NE nor E
changed in the high-level individuals, it would be unwise to link low BLC with low SNS response.
Moreover, data in similar groups during functional electrical stimulation (FES) cycling does not
show the same degree of disparity in catecholamine’s123,127 and unpublished data128 from our
laboratory indicate that above T4 SCI exhibit high BLC during FES and ACE. While level of injury
may play a role in lactate response, other factors including motor unit recruitment, muscle fiber type
and individual drive also play a significant role. Alternatively, venous pooling in the lower
extremities could artificially increase BLC by reducing total blood volume in the system. Therefore,
far more work is needed to fully elucidate the lactate response for persons with SCI.
One special note must be made regarding the reflexive hypertonicity, or muscle spasticity,
below the level of injury in SCI. Spasticity is often a double edged sword, believed to help preserve
muscle and bone mass8,129, but can greatly diminish quality of life and functionality in SCI8,114.
Fortunately, lower extremity exercise has been shown to reduce spasticity in SCI130, making exercise
an important facet to long-term care.
In summary, disruption of the combined neuroendorine system will impact cardiac response
to exercise, as well as the hemodynamic responses. Moreover, pulmonary limitations may impact
maximal activity, but probably do not significantly impact training in SCI T10 and below. Finally, it
appears that the acute lactate response in SCI is influenced, but not determined by the SNS, and is
more likely inflenced by the mode of activity, lower extremity venous stasis and the overall work
capacity. Additionally, SCI appear to exhibit a similar lactate elimination as able bodied125, but may
exhibit higher submaximal BLC under certain conditions. Of particular note, is the potential for
diminished respiratory buffering capacity in high level para and tetraplegia due to impair ventilatory
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capacity and venous pooling. Taken together, these changes can have important implications on how
BLC after SCI is interpreted and how exercise should be prescribed for individuals with SCI.
Chronic Exercise Adaptation
Our understanding of the endocrine system’s role in exercise adaptation has expanded
significantly in the past decade. Many of the acute responses following an individual training session
act serially to produce a larger chronic adaptation, whether positive or negative. For example, muscle
remodeling following training is a balance of catabolic breakdown (e.g., cortisol) that enables
anabolic hormones, like growth hormone and testosterone, to restructure and rebuild a muscle more
capable of responding to the stress placed on it. For able-bodied this process functions normally,
while in SCI, hormonal disruption may make adaptation more difficult.
As previously discussed, SCI suffer a wide range of neuro-endocrine disruption, which
influences acute exercise and chronic training adaptation. Generally speaking, men with SCI can
exhibit clinically low testosterone and free testosterone131, which can have broad impacts on
individuals, including limiting strength gains from RT and muscle adaptation and recovery following
training132. Additionally, growth hormone (GH), and its surrogate measure IGF-1, may be blunted
among SCI131,133,134. These findings were strengthened recently by Bauman et al.135, where
monozygotic twins displayed divergent GH responses, with SCI twins presenting reduced GH.
Clinically and metabolically, this latter finding is probably more important due to the extensive role
GH plays in the body at maintaining body weight, blood glucose maintenance during activity, and
tissue remodeling/recovery after exercise. Therefore, care must be taken to balance the training
stimulus with adequate recovery. The anabolic imbalance may also extend to estradiol, as well,
which has been shown to be higher among SCI than their non-SCI twin. The cause is believed to be
increased fat mass present in SCI136. Nevertheless, it seems unlikely estradiol offers significant
protective effect from bone loss. It also highlights the complexity of changes following SCI. Thus,
careful consideration must be given to both the short and long-term planning of exercise training in
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SCI to account for these alterations. Additionally, more data are needed in elucidating the potential
impacts that various training protocols might have on enhancing the endocrine response in SCI.
Exercise Application: Training in SCI
Upper Extremity Endurance Exercise
Without doubt the greatest limiting factor for training SCI is that most are constrained to
upper extremity exercise. Whether it be wheelchair pushing, arm crank or hand cycling, or resistance
training, arm exercise is the most convenient and cost effective exercise strategy for SCI. Arm crank
ergometry (ACE) may offer a conveniant training option for enhancing both cardiovascular fitness
and caloric expenditure, despite the relatively small available muscle mass137. Moreover, the human
shoulder joint is not ideally suited to repetitive endurance activity and arm exercise will often
exacerbate overuse issues in the shoulder without appropriate prophylactic resistance exercise is
added. In spite of this, numerous studies have support the use of arm exercise as a core part of
training SCI, particularly paraplegics.
ACE, and to a lesser extent wheel chair or hand cycling, are probably the most common and
easily accessible exercise modalities for wheelchair bound persons and have been studied
extensively103,109,138-151. Early ACE training has shown varying results, with some showing minimal
cardiovascular benefits from 8 weeks of low-moderate intensity training 20 min.day-1, 3 days.week-1
152

, while other data indicated that 16 weeks of ACE had a significant impact on fitness 151, and that

high resistance ACE can also improve upper extremity strength153. Upper extremity strength is
positively related to endurance performance109. Due to the physical limitations faced by increasingly
higher injury levels, it has been suggested that level of injury was a major factor affecting ACE
improvements114. However, most data show significant cardiovascular improvement103,114,141
following prolonged intensive training, suggesting that a balanced approach to intensity can make
the difference between minimal and optimal improvement. For example, de Groot et al. et al.

154

showed that ACE training at 80% heart rate reserve (HRR) was more effective at improving VO2 Peak,
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insulin sensitivity, and lipid profiles than 60% HRR. Indeed, data from our lab indicates that
motivated SCI training over a period of months can make large improvements in ACE performance.
One subject was shown to improve ACE VO2 Peak by more than 50% in just 5 weeks of training.
Thus, SCI can achieve significant improvements with a well designed training program.
Additionally, it would appear that simulataneous ACE and FES cycling – referred to as hybrid
training, can significantly impact the acute exercise response in SCI155. It is likely, that the addition
of FES to upper extremity exercise mitigates hypokinetic circulation, improving cardiac output.112
Thus, hybrid training may offer an additonal training or testing tool for individuals with SCI.
Lower Extremity FES Leg Cycle Ergometry
In contrast to upper body exercise, FES training of the legs has both metabolic and
performance consequences. Data from FES resistance training (typically leg extensions), saw a 7 –
30 fold increase in force production156,157, 20-40% increase in thigh cross-sectional area, improved
oral glucose tolerance tests (OGTT)156, and decreased intramuscular fat, which may significantly
improve insulin sensitivity158,159. Despite its endurance nature, FES cycling provides a weak
cardiovascular benefit, but has shown promising results restoring leg muscle mass156,160. However,
FES training is often even less accessible than either arm crank or wheelchair training options. FES
training as a whole, whether it be cycling or leg extension exercise, can have a substantial impact in
SCI. Functionally speaking, Lui et al.161 showed a 3-6% in Torque (Nm) and 2.3% increase in lean
mass after just 8 weeks of FES cycling, while Petrofsky et al.157 saw force (KP) increase 55% after
12 wk of leg cycling. Likewise, Duffell et al.162 showed significant improvements in FES cycling
over the course of one year’s training. More importantly, studies support the positive impact FES has
on metabolic parameters163-165. For example, Mohr et al.165 showed that a year of FES significantly
improved insulin sensitivity and GLUT-4, while more recently, Griffin et al.163 showed that just 10
weeks of FES cycling improved glucose tolerance tests and reduced inflammatory markers like IL-6
and CRP.
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Improvement in insulin sensitivity is typically associated with a reduction in adipose tissue,
however, our understanding of muscle fiber typing among SCI, as well as extended training data
supports peripheral enhancement of glucose uptake. For instance, after a year of training, Mohr et
al.44 showed a reversal of Type II fibers; prior to training 63% of the muscle was Type IIx and 33%
Type IIa, while at the completion of training the breakdown was 32% and 61%, respectively. Even
more interesting were data by Crameri et al.166 showing similar trends in as short as 10 weeks; Type
IIa fibers increased from ~25% to nearly 80% by the end of training. These two papers suggest the
profound impact FES may have metabolically, improving insulin sensitivity from a route typically
unseen in the general population and has important implications for long-term management of SCI. It
is unclear what amount of continued FES is needed to maintain these outscomes, however.
Upper Extremity Resistance Training
Few modalities available address the importance of upper body strength in performing
ADL.107,109 Available data among applicable special populations with similar co-morbidities,
indicate that RT could be a powerful tool in treating SCI related ailments. For example, Kraemer et
al.167 have shown that older adults still show a high degree of improvement following RT, and that
RT may potentiate their diminished endocrine response. While less extensive, RT data from studies
using SCI persons suggest that it is an important component for improving strength and overall
fitness, likely improve one’s ability to perform ADL’s and reducing shoulder dysfunction101,109,
_ENREF_6but little is known about its affect on insulin sensitivity. In contrast, upper body (UB)

training can often show considerable crossover. For example, both Nash et al.156 and Jacobs et
al.145,149 have shown impressive improvements in both aerobic (e.g., VO2 Peak), strength, and power
(e.g., Wingate) measures following either circuit resistance training or more traditional RT. Most
interesting of these, however, is Jacobs

145

study showing that moderate RT is equally effective at

improving aerobic fitness and Wingate power as moderate intensity arm crank training, while only
RT improved strength measures. This last finding is important, because as Janssen et al.107 and
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Zoeller et al.109 have shown, upper extremity strength plays an important role in an SCI person's
ability to perform ADL. Moreover, Nash et al.101 indicated that appropriate RT not only improves
fitness, but also reduces shoulder pain, which is endemic and debilitating in SCI.
Metabolically, Kirk et al.168 have shown that even minimal RT can result in a chronic
increase in energy expenditure and even increase GLUT-4 content in able bodied subjects.57 This last
finding is important, because other research169 has suggested that RT only improves glucose disposal
due to an increase in muscle mass, and thus creates a larger source of disposal. However, recent data
170

further supports Tabata’s57 work, suggesting that like aerobic training, RT may have an innate

ability to improve glucose metabolism. For example, Black et al.170 showed that acute RT may
improve insulin sensitivity in individuals with impaired glucose metabolism. It is unclear what
additional influence lower body FES resistance training might have in this population.
Lower Extremity FES Resistance Training
A review of the literature for FES RT among SCI offers promise but also highlights the
limitations of FES in SCI. For instance, unlike upper body RT, which may often look very similar to
any program in the general population, lower body activity in SCI is often reliant on FES, where the
paralyzed musculature is stimulated to either produce or enhance an individual’s muscle
contractions156,157,160,161. Therefore, true resistance training as most are familiar with has not been
studied, and has typically been limited to FES leg extensions156,160 or even FES cycling

157,161

.

Further complicating these data are the small sample sizes used, making broad interpretations and
recommendations difficult at best. Despite these shortcomings, available data suggests promising
results from RT. For example, simple leg extensions have been shown to increase force production
upto 30%156,171 and cross-sectional area 40% 160, while decreasing intramuscular fat of the legs159 and
improving glucose tolerance156. Additionally, Petrofsky and Laymon157 demonstrated that even
short-term FES RT can significantly improve FES cycle training. Nonetheless, there are little data on
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RT representative of whole leg able-bodied training, nor information on the endocrine repsonse to
either upper or lower body RT.
Finally, no research to date has examined the combined impact of upper body RT with lower
body FES RT and it is unclear how a more traditional approach to whole body resistance training
would influence health or fitness in SCI persons. For example, preliminary data from our lab
indicates that ACE caloric expenditure is significantly higher than FES (4.3 vs. 2.5 kcal.min-1), but
the addition of hybrid FES training improves ACE performance in SCI. Whether the combined
training would further enhance caloric expenditure of ACE is still unclear, though. It is reasonable to
expect significant improvements from combined RT, as well. However, the very nature of SCI
makes transporting individuals and retaining them for a three-month training period daunting.
Moreover, reduced sympathetic nervous input and hormonal disruptions, particularly clinically low
testosterone in men

172

, may have broad implications on long-term training adaptations in SCI that

alter resistance training outcomes. Thus, much initial work is required.
Practical Exercise is Medicine Rx
For physicians, a major tenet of medicine is to first, do no harm, perhaps exercise
physiologists should adopt the major tenet to do the most good. In contemporary society, weight loss
is often not just the primary goal, but the only goal for individuals, while research suggests that
weight loss may not be needed for improvement in metabolic improvements58. In comparison, health
professionals have largely focused on cardiovascular or aerobic fitness in an effort to improve
cardiovascular function, while ignoring both resistance training and HIT. The belief has been that
reducing cardiovascular disease and burning the most calories in an exercise session were of
paramount importance. However, for a population suffering from significant metabolic disease that
ultimately increases one’s risk for CVD, it seems more logical to address and mitigate their risk
factors, while improving their functionality – defined here to be the ability to perform ADL and
community mobility, and their ability to adhere to a structured exercise program. While it may not be
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possible for many with SCI to accrue recommended weekly energy expenditures, expenditures low
as 1000 kcals.week-1 can lead to significant loss in body fat, despite a divergent cardiovascular
response between FES cycling and ACE. Thus, long-term exercise planning may require a multimodal approach.
As research has shown145,147,149,173, persons with SCI may actually benefit as much or more
by either supplementing endurance training with strength training, or simply using strength training
alone. Such a paradigm may improve retention rates and positive lifestyle changes with the goal of
adding more cardiovascular training as one makes progress. There is good reason for using one mode
of activity to build functional ability or interest, later adding new activities. For example, data among
obese adolescents shows a high affinity towards resistance training, with long term compliance near
90%, with significant improvement in insulin sensitivity; many of these participants move on to
other traditional endurance activities like cycling and swimming174. SCI may be a more complex
population, but that may mean greater critical thought on solutions, including using two or more
modalities. In particular, increased body weight/fat limits one’s ability to perform ADL’s and
reduces mobility within their community. Added strength enhances wheel chair propulsion and
transfer ability, which will improve overall activity, which are important in long-term compliance.
It is a long-held belief that combining endurance and strength training leads to compromised
gains in individuals without disability175-177, and that strength training alone provides no significant
cardiovascular benefits, which may not entirely apply to SCI145. Thus, it appears that non-traditional
modalities may offer similar, if not superior short-term fitness results than modalities like submaximal ACE or wheelchair training, while reducing the risk for upper extremity injury99,109,144. For
the general population, these data offer a powerful tool in managing risk factors and improving
endurance capacity in the short-term. In SCI, SIT may prove even more valuable in the short and
long-term management of MtS. At present, no data are available on HIT or SIT using ACE, and
therefore, the literature is bare with regard to HIT in SCI. Existing data51,103,146,178 show that Wingate
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workloads and power outputs are considerably lower for ACE than they are for leg ergometry and
inversely related to the level of the SCI146,178. Early work using SIT in our lab179, suggests that SCI
have a high capacity for upper body work and SIT may improve insulin sensitivity, but the overall
magnitude may be less than leg ergometry. For example, subjects improved their average work
(kj)/sprint by more than 10% after just six sessions, while insulin sensitivity improved by 7%, which
are smaller than leg sprint studies.83,93,94 It is yet unclear from this limited data whether the reduced
response is due to lower absolute work rate, the age of the participants – ~50 years, the high degree
of obesity – 35% fat, SCI or a combination of any of these factors. However, data by Gibala’s
group86 indicates that high intensity leg cycling is an effective training tool among obese, diabetic
and elderly populations, suggesting that SCI may achieve more modest improvements.
This brings to light a major limitation of SCI research, which is the heterogeneity of the
population, which often makes study design complicated and interpretation of results difficult. For
instance, it is as difficult to compare a person with T10 SCI with a person with C5, as it is a T4
complete injury with an ambulatory T4 for any or all of the reasons outlined earlier. Cardiovascular,
metabolic, physical mobility and strength all differ, and may even differ between two individuals of
equal level and complete injury. Furthermore, the variability in population makes recruitment of
adequate subject pools challenging at best, particularly among motor complete, and even more so
among cervical level motor complete injuries. Therefore, a great deal of thought must be given to
study design, with liberal timelines for data collection. Further complicating research are competing
protocols and levels of remuneration, practicality of completion, and subject commitment. All of
which will influence the direction of study designs.
Future Directions
21st Century Exercise Rx
One might conclude that persons with SCI are a complex population that should be treated
with caution due to the limitations and health issues they face. However, participants at our lab have
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proven that with sufficient motivation, SCI are indeed capable of undergoing strenuous training, and
making large improvements without large decreases in body fat. Therefore, it would seem that
exercise prescription should use both caution and sound training principles that includes long-term
planning for training SCI. It also appears that multi-modal training, likely utilizing both lower FES
cycling and upper extremity exercise, may yield the greatest overall results, and that appropriate
shoulder strengthening can improve shoulder function and reduce shoulder pain

99

. Additionally,

both heavy resistance training and circuit resistance training yield impressive results in strength,
power, aerobic fitness and even blood lipids145,147,149,150,173. Finally, while little data exists, it appears
that either HIT or SIT are viable options for training SCI and should be considered for capable
individuals. Nonethelss, based on current ACSM guidelines180 most SCI fall into the moderate risk
category influencing early assessment and programming. Thus initial screening and testing are
important.
Following a full risk factor assessment, graded exercise testing should be considered based
on common ACSM guidelines180, as well as those absolute and relative contraindications specific to
SCI, as summarized in Table 4.181 Training prescriptions should account for individuals goals and
risk factor reduction, and consideration should be given to factors limiting recovery to ensure
adequate adaptation occurs. Inspite of the broad, often far-reaching health problems among SCI,
exercise must be a key component of long-term SCI treatment.
Research
It would seem that research among SCI is nearing a critical mass. Nonetheless, much work
needs to be in understanding the optimal training methodology in SCI. While this may prove near
impossible due to the heterogeneity of the popular, more data are needed to allow better conclusions
on mitigating or reversing MtS in SCI. Specifically, several emerging lines of research warranting
further study include:
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•

Acute effects of SIT or HIT in SCI – it is unknown whether a single session of high intensity
training will yield improved insulin sensitivity182, or whether there are changes in any of the
regulatory apparatus from ACE training73.

•

Short-term training effects of ACE SIT in non-SCI populations – clearer understanding is needed
on the impact of ACE SIT in upper body limited populations besides SCI.

•

Effects of combined, multi-modal training effects in SCI – more work needs to look at the use of
simultaneous upper body and lower body activity in SCI, particularly, combined ACE HIT and
FES cycling both in acute and long-term training studies and whether combined training presents
an increased risk of overtraining.

•

The acute and chronic effects of combined RT in SCI – Little is known about the endocrine
response to such training, or the long-term benefits. Further, the combined modality may yield
changes in body composition that upper or lower body training has not.

•

Relationship between fiber type, lactate response and fiber type conversion following FES.

•

Development of better maximal and submaximal exercise test methodology, as well as criteria
for determining VO2 Peak in SCI; e.g., utilizing hybrid ACE-FES or Nu-Step training system
Persons with chronic SCI face milieu of health problems, many of which center around the

development of obesity, metabolic syndrome and ultimately cardiovascular disease. Therefore, the
medicinal qualities of exercise offer great potential for treating SCI. Unfortunately, SCI are a highly
diverse and challenging population to effectively train, with much still poorly understood.
Nonetheless, the challenges of training provide exercise physiologists and clinicians an immense
opportunity to both further our understanding of exercise responses and extend our knowledge of
exercise in SCI. Furthermore, a great deal more research is needed unravel how best prescribe
exercise in this special population.
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Table 1. Life expectancy and lifetime costs for spinal cord injury by age group and severity of
injury.

* Adapted from National SCI Statistical data 183

Table 2. Comparison of criteria for determining metabolic syndrome as determined by ATPIII,
WHO and AACE. ATPIII and WHO use a strict criteria list, while AACE rely on clinical judgment
based on risk factors.22
ATP III

Obesity
Waist Circumference
>102 cm (Men)
>88 cm (Women)

BMI > 30 kg.m2

WHO

AACE

BMI > 25 kg.m2

Blood Lipids
Triglycerides
> 150 mg.dl-1

Blood Pressure
Systolic
> 130 mm Hg

HDL
< 40 mg.dl-1
< 50 mg.dl-1
Triglycerides
> 150 mg.dl-1

&/or
Diastolic
> 85 mm Hg
Systolic
> 140 mm Hg

HDL
< 35 mg.dl-1
< 39 mg.dl-1

&/or
Diastolic
> 90 mm Hg

*
Type 2 diabetes
Impaired fasting
glucose
Impaired glucose
tolerance

Triglycerides
> 150 mg.dl-1

Systolic
> 130 mm Hg

Fasting Glucose
110 – 126 mg.dl-1

HDL
< 40 mg.dl-1
< 50 mg.dl-1

&/or
Diastolic
> 85 mm Hg

2 hr post glucose
challenge
140 mg.dl-1

* Primary criteria plus any two others
!
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Glucose
Fasting Glucose
> 110 mg.dl-1

Other

Urinary albumin
secretion
> 20 µg.min-1
Or
Albumin: creatinine
ratio
> 30 mg.g-1
Family Hx or at risk
ethnicity for Type 2
diabetes,
hypertension, or
CVD
Polycystic ovary
syndrome
Sedentary
Advancing age

Table 3. Overview of neurological assessment form used by the American Spinal Injury Association
to classify spinal cord injury impairment.110

Table 4. Absolute and relative contraindications to exercise testing for paraplegic and tetraplegic
persons. Adapted from ACSM’s Resources for clinical Exercise Physiology.181
Absolute
Autonomic dysreflexia
Severe pressure sore/wound
Symptomatic hypotension
Illness related acute urinary tract infection
Uncontrolled spasticity/pain
Unstable fracture
Uncontrolled environmental heat
Inability to safely seat person during testing
Insufficient range of motion during activity

Paraplegia
√
√
√
√
√
√

Relative
Asymptomatic hypotension
Muscle/Joint discomfort or pain

!

√
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Tetraplegia
√
√
√
√
√
√
√
√
√

√
√

Figure 1. All causes for spinal cord injury.2

Figure 2. Model present by Wilt et al.1 for the development carbohydrate and lipid disorders and
their contribution to cardiovascular disease among chronic spinal cord injury.
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Appendix B. Pilot Data
All data presented are means + se. Analyses included both ANOVA with post-hoc Tukey tests, as
well as Wilcoxon Sign Rank Tests. Due to the agreement between the aforementioned tests, only
ANOVA results are presented.
A total of 12 subjects (females = 4) were used for sprint performance comparison. To accommodate
data collection, both males and females were chosen to represent a wide range of abilities. Of the 12
subjects, 8 (3 females) were used for the main analysis comparing a 4 min Tabata with 5 Wingate
sprints. The remaining subjects completed most testing, including a 5 min Tabata (identical to Tabata
outlined in methods, but session adds an additional 2 sprints), which was used to estimate the
additional kJ expenditure for our 8 subjects. From these subjects, it was seen that adding 2 additional
sprints increased kJ expenditure 6-8 kJ; the 5 min Tabata estimate uses the lowest value of 6 for the
analysis.
The overall findings from the pilot study indicate a 4 min Tabata session will expend a significantly
lower amount of kJ (Table 1). However, adding an additional minute to the training adds at least 6 kJ
of work and negates this difference. Interestingly, our WIN kJ expenditure compares favorably to
data published by Whyte et al. (2012) (61.7+ 2.9 kJ). This indicates that using a 5 min Tabata session
will allow us to match kJ expenditure with Wingate sessions and maximize the likelihood of a
significant myokine response similar to Nielsen et al. (1996).
Whyte et al. (2012) have proposed that energy (ATP) turnover may be the mitigating factor for acute
improvement in insulin sensitivity. In their study, the rate of kJ expenditure was 5-6 fold higher for
the ~3.3 min “sprint”, which is comparative to the data presented here which was ~4 fold higher for
Tabata. Thus, if 6 min of VO2 max exercise (Nielsen et al. 1996) increases IL-6, then it is reasonable
to expect that a 5 min Tabata (well over 100% relative VO2 max intensity) will increase IL-6 and
improve Si. Our pilot data (Figures 1 and 2) indicate a consistent and possibly significant increase in
IL-10 following 5 min of Tabata training in 5 college age males.
Table 1. Comparison of mean kJ expenditure for 8 subjects following a 4 min Tabata (TAB 4), 5
Wingate (WIN) sprints, or the estimated kJ for a 5 min Tabata (TAB 5 est). *Denotes a significantly
higher (p<0.05) kJ expenditure from TAB 4; adding 2 additional sprints negates this difference.
SIT

kJ

SE

TAB 4

47.0

3.61

TAB 5 est

53.0

3.61

WIN

61.6

3.61

!
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Figure 1. IL-6 at base line and after Tabata training. P = 0.2477

Figure 2. IL-10 at base line and after Tabata training. P = 0.0426
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VCU RESEARCH PLAN TEMPLATE
Use of this template is required to provide your VCU Research Plan to the IRB. Your responses should be written in terms
for the non-scientist to understand. If a detailed research protocol (e.g., sponsor’s protocol) exists, you may reference
specific sections of that protocol. NOTE: If that protocol does not address all of the issues outlined in each Section
Heading, you must address the remaining issues in this Plan. It is NOT acceptable to reference a research funding
proposal.
ALL Sections of the Human Subjects Instructions must be completed with the exception of the Section entitled
“Special Consent Provisions.” Complete that Section if applicable. When other Sections are not applicable, list the Section
Heading and indicate “N/A.”
NOTE: The Research Plan is required with ALL Expedited and Full review submissions and MUST follow the
template, and include version number or date, and page numbers.

DO NOT DELETE SECTION HEADINGS OR THE INSTRUCTIONS.
I. TITLE
Comparison of two different work to rest ratios on the acute metabolic and inflammatory effects of a single bout of
sprint interval training

II. RESEARCH PERSONNEL
A. PRINCIPAL INVESTIGATOR
List the name of the VCU Principal Investigator
Edmund Acevedo
B. STUDY PERSONNEL
NOTE:
1. Information pertaining to each project personnel, including their role, responsibilities, and qualifications, is to
be submitted utilizing a VCU IRB Study Personnel Information and Changes Form. This form is available at
http://www.research.vcu.edu/forms/vcuirb.htm.
2. A roster containing a list of project personnel is to be maintained as a separate study document which is
retained with the Research Plan, and is to be updated as applicable. The roster is to include all VCU project
personnel (including the principal investigator) who are engaged in this research protocol, as well as non-VCU
personnel who are also engaged but do not have local IRB approval for this protocol from their own
institution,. This template document, entitled VCU IRB Study Personnel Roster, is available at
http://www.research.vcu.edu/forms/vcuirb.htm.
C. Describe the process that you will use to ensure that all persons assisting with the research are adequately
informed about the protocol and their research-related duties and functions.
All study personnel have completed VCU CITI research training. Personnel will take part in all research planning meetings
and be trained and practice all study related duties prior to data collection. Personnel will all be familiarized with lab safety
procedures and basic CPR.
III. CONFLICT OF INTEREST
Describe how the principal investigator and sub/co-investigators might benefit from the subject’s participation in this
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project or completion of the project in general. Do not describe (1) academic recognition such as publications or (2)
grant or contract based support of VCU salary commensurate with the professional effort required for the conduct of
the project
Chris Harnish will be completing this research as part of his doctoral training, while Dr. Acevedo, the PI and advisor; will
complete his role as Mr. Harnish’s advisor. The basic questions answered by this research will further the understanding of
the role that specific exercise modes, shaping more expansive research in the future.
IV. RESOURCES
Briefly describe the resources committed to this project including: (1) time available to conduct and complete the
research, (2) facilities where you will conduct the research, (3) availability of medical or psychological resources that
participants might require as a consequence of the research (if applicable), and (4) financial support.
The majority of data collection will take place in the morning hours. Chris Harnish will manage all data collection,
and has weekday mornings allotted specifically for research. The duration of the study is partially dependent upon subject
recruitment success. However, we believe all subjects can be identified, enrolled and completed between 2 and 6 months
after beginning the study. Mr. Harnish has submitted grant proposals to the National Strength and Conditioning
Association and Foundation for Aging and Exercise Science for support of this project. Nonetheless, the Dept. of Health
and Human performance has pledge to support this project to its completion. The Virginia Commonwealth University’s
(VCU) Exercise Physiology lab is well equipped with the tools needed to complete this research, including a Parvo
OneMax VO2 system, YSI blood lactate analyzer and polar heart rate monitors, as well as all body composition analysis
equipment. Oral glucose tolerance tests (OGTT) will be conducted at the VCU Center for Clinical and Translational
Research (CCTR). OGTT’s will be administered by the principal investigator with the aid of a trained research nurse.
Blood samples will be prepared and transferred to the Clinical Research Service (CRS) lab for analysis.
The principle investigator of this study has extensive experience conducting research studies, and is familiar with
all of the techniques and equipment used in this study. Statistical design and analysis consultation will be provided by Dr.
Roy Sabo from the VCU Dept. of Biostatistics. Dr. Sabo has extensive experience in biomedical statistical analysis and
was intimately involved in our prior arm crank sprint study in spinal cord injured persons.
V. HYPOTHESIS
Briefly state the problem, background, importance of the research, and goals of the proposed project.
Exercise intensity is a critical stimulus for endurance training adaptations and metabolic regulation. Several contemporary
lines of research have shown that a variety of low volume, sprint interval training (SIT) programs are effective at eliciting
significant metabolic changes, including increased mitochondrial function and insulin sensitivity (Si). However, little is
known on how work to rest ratio (W:R) interacts with these protocols; it is well-known that short rest periods during highintensity training elicits a larger neuro-endocrine response than similar volumes of moderate intensity training. In addition,
recent research has suggested that muscle-derived inflammatory cytokines, termed myokines, are intimately involved in
fuel regulation during and after exercise. It is believed that activation of large muscle groups leads to rapid increases of
circulating IL-6, which positively influences IL-10 following exercise; both of these cytokines are seen as key players in
the management of blood sugar. Research has been inconclusive on the acute impact of high-intensity interval or sprint
interval training on this myokine/cytokine release. Likewise, little is known on the impact of manipulating W:R on their
release, as well. Therefore the purposes of this research are to compare the acute (i.e., 1, 24 hr post) inflammatory and
metabolic responses to SIT of different W:R. Twelve to sixteen males and twelve to sixteen females ages 18-35 will be
recruited to completed a cross-over comparison of two SIT interventions; either the more recently tested Wingate protocol
(five 30 sec sprints with ~4 min recovery), or a Tabata protocol (ten 20 sec sprints with 10 sec recovery). Subjects will
complete oral glucose tolerance tests to assess Si and blood tests to determine IL-6, TNF-a, and IL-10 levels at baseline,
prior to each training session and ~24 hr after exercise. Following SIT, we hypothesize that Si will improve 24 hr after
Tabata but not Wingate training, and will be proportional to increases in both IL-6 and IL-10.
VI. SPECIFIC AIMS
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It is widely accepted that acute and chronic endurance and high-intensity interval training enhance Si. In comparison, it
appears that chronic, but not a single bout of SIT will improve Si. It is unclear whether a single bout of SIT using a low
W:R, like that proposed by Tabata et al. (1996), could improve Si; many of the mechanisms for such a response remain
undefined. Exercise is generally anti-inflammatory (Brandt and Pedersen 2010) in the sense that on balance, antiinflammatory myokines like IL-6 and IL-10 exceed inflammatory cytokines like TNF-a (Ropelle et al. 2010), and that the
release of IL-6 is proportional to the intensity and muscle mass utilized during training. Further, IL-10 has been proposed
as a major influence on Si at rest (Staczkowski et al. 2005), and Steensberg et al. (2003) have shown that IL-6 infusion
enhances IL-10 release. However, the relationship between Si, IL-6 and IL-10 following SIT are unclear, but should follow
trends similar to those published by Meckel et al. (2009; 2011) following sprint running. We hypothesize that SIT utilizing
brief rest periods, but similar total work will elicit a greater myokine response, and that this larger myokine release will
positively influence the acute improvement in Si. Based on the current literature and our own pilot work, we hypothesize
that:
1. SIT with a higher W:R (i.e., Tabata) will improve Si, whereas SIT using a lower W:R (i.e., Wingate) will not.
2. Either SIT protocols will increase IL-6 release, however, Tabata training will elicit a greater response
immediately post-exercise, and at 1 hr post.
3. IL-10 increases following training will be proportional to IL-6 increases, but Tabata training will elicit a larger
IL-10 release, which may further positively influence Si.
VII. BACKGROUND AND SIGNIFICANCE
Include information regarding pre-clinical and early human studies. Attach appropriate citations.
Exercise can be effective in reducing body fat (Sigal et al. 2004; Volek et al. 2005; Thorogood et al. 2011),
however, it is far more effective at improving many of the components of metabolic syndrome, including insulin
sensitivity (Sigal et al. 2004; Earnest 2008; Colberg and Grieco 2009). Insulin sensitivity (Si) and glucose effectiveness, or
the ability to uptake glucose into the cell, are driven by a number of factors that include translocation of glucose
transporter 4 (GLUT4) inside the cell, and capacity and density of the mitochondria (Bournat and Brown 2010). The link
between improved mitochondrial function and GLUT4 expression led Earnest (2008) to hypothesize that high-intensity
interval training provides a more powerful stimulus to improve Si than moderate aerobic exercise, directly impacting
aerobic metabolic processes. Several researchers (Gibala 2011; Babraj et al. 2009; Burgomaster et al. 2008) have
demonstrated that brief bouts of sprint interval training (SIT) can elicit improvements in oxidative capacity, metabolic
function and Si that are analogous to moderate intensity endurance training.
Babraj et al. (2009) showed that six sessions of SIT improved insulin sensitivity by 37%, while other groups have
reported similar findings among obese men (Whyte et al. 2010) and obese women (Trilk et al 2011). In contrast, a single
bout of SIT appears ineffective at improving Si (Brestoff et al. 2010; Whyte et al. 2012), raising questions about how SIT
improves insulin sensitivity over time. A more recent report by Whyte et al. (2012) demonstrated that a single maximal
200 sec “sprint” significantly improved 24 hr sensitivity, while a single session of SIT, eliciting the same kJ expenditure,
did not. This supports the idea that acute mitochondrial energy turnover, or flux, may be the key variable in acute
improvements (Thyfault 2008). Thus, individual SIT sessions, with their intermittent work bouts and long rest periods, do
not tax mitochondria sufficiently, but appear to initiate overall mitochondrial biogenesis (Gibala et al. 2009). It is unclear
whether sprint training utilizing minimal rest periods will elicit acute improvements in Si. Furthermore, little is known
about the mechanisms for acute SIT responses.
Many possible potentiators of Si exist that may enhance GLUT-4 response, including IL-6 and IL-10 (Febbraio
and Pedersen 2002), or indirectly, by improving fatty acid mobilization and utilization in the mitochondria (Thyfault
2008), and upregulation of mitohondria generators AMPK and PGC-1! (Gibala et al. 2009). More recently, alterations in
pro (e.g., TNF-a and IL-6) and anti-inflammatory (e.g., IL-10) cytokines have been implicated as mediators of glucose
regulation at rest (Staczkowski et al. 2005), while muscle derived cytokines, better termed myokines, may play a key role
in glucose regulation during and after exercise (Febbraio and Pedersen 2002; Hong et al. 2009; Brandt and Pedersen 2010).
Moderate to high intensity exercise is known to be a potent stimulus for IL-6 release from muscles (Febbraio and
Pedersen 2002), but less is known about short duration maximal sprint exercise. For example, 6 min of maximal rowing
has elicited a 2-fold increase in IL-6 (Nielsen et al. 1996), while Meckel and colleagues (2009; 2011) have shown that run
sprint training can also have a significant increase on IL-6. Whether the release of IL-6 and IL-10 play a role in acute
improvements in Si remain to be seen, as no study to date has examined this possible mechanism. Additionally, research
comparing the impact of W:R on any of the aforementioned responses in glucose metabolism and possible inflammatory
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relationships is lacking. Exercise professionals and coaches understand that W:R can drastically impact metabolic stress,
cardiovascular demand, and even potentiate the endocrine response during training (Gray et al. 1993), but little is known
about how W:R would impact cytokine release during SIT.
In light of the current interest in sprint interval training, but the dearth of data on the acute (i.e., 1 – 24 hr post)
response to sprint interval training of different W:R, it would be prudent to compare two sprint protocols of similar total
work (kJ) but distinctly different W:R. Further, it is important to elucidate the inflammatory response pathways that are
activated following these activities. In particular, it is believed that both IL-6 and IL-10 play important roles in
carbohydrate regulation, but it is unclear how either relates to Si following sprint interval training. Therefore, the purpose
of this study would be to compare the Wingate SIT protocol with a modified Tabata protocol (Tabata et al. 1996), where
subjects complete 20 sec maximal sprints with 10 sec recovery for a total of 5 min. Recent pilot work (n=5 males, 5 min
Tabata) indicated that both IL-6 and IL-10 will increase within 1 hr of exercise.
VIII. PRELIMINARY PROGRESS/DATA REPORT
If available.
N/A

IX. RESEARCH METHOD AND DESIGN
Include a brief description of the project design including the setting in which the research will be conducted and
procedures. If applicable, include a description of procedures being performed already for diagnostic or treatment
purposes.
The experimental protocol (Figure 1) will be similar to previous SIT studies, and will consist of a one-week intra-subject
control period, with baseline (B) and pre-training (PRE) oral glucose tolerance tests (OGTT) and plasma myokine
analyses. Subjects will then perform two different acute SIT protocols – Tabata and Wingate, utilizing a cross-over trial
design, with each training bout separated by no less than one week. Half the subjects will perform the Tabata first, while
the other half will perform the Wingate first. All exercise will take place using a mechanically braked Monark Peak Bike
(Monark Exercise AB, Sweden). Blood samples (~10 ml) will be taken immediately following, and 1 hr after each training
session, as well as prior to the 24 hr post-exercise OGTT (Febbraio and Pedersen 2002). Each exercise session will last 30
minutes or less.
Figure 1. Graphic summary of the experimental design for the study. Note: OGTT=oral glucose tolerance test, SIT =
sprint interval training, TAB = Tabata – 10X 20 sec sprints/10 sec rest, WIN = Wingate – 5X 30 sec sprints/240 sec rest.

X. PLAN FOR CONTROL OF INVESTIGATIONAL DRUGS, BIOLOGICS, AND DEVICES .
Investigational drugs and biologics: IF Investigational Drug Pharmacy Service (IDS) is not being used, attach the IDS
confirmation of receipt of the management plan.
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Investigational and humanitarian use devices (HUDs): Describe your plans for the control of investigational devices
and HUDs including:
(1) how you will maintain records of the product’s delivery to the trial site, the inventory at the site, the use by each
subject, and the return to the sponsor or alternative disposition of unused product(s);
(2) plan for storing the investigational product(s)/ HUD as specified by the sponsor (if any) and in accordance with
applicable regulatory requirements;
(3) plan for ensuring that the investigational product(s)/HUDs are used only in accordance with the approved
protocol; and
(4) how you will ensure that each subject understands the correct use of the investigational product(s)/HUDs (if
applicable) and check that each subject is following the instructions properly (on an ongoing basis).
N/A
XI. DATA ANALYSIS PLAN
For investigator–initiated studies.
All data will be presented as means ± SE. The Cederholm index, which represents peripheral insulin sensitivity,
will be calculated using the formula:
ISICederholm = 75000 + (G0-G120) ! 1.15 ! 180 ! 0.19 ! BW/120 ! Gmean ! log (Imean)
-1

BW = body weight, G0 and G120 are plasma glucose concentration at 0 and 120 min (mmol·l ), and
-1
Imean and Gmean are the mean insulin (mU·l 1) and glucose (mmol·l ) concentrations during the OGTT.

All training responses will be analyzed using repeated measures ANOVA with post hoc Tukey tests as follows:
1. A 2 X 4 model used to assess the effect of SIT on IL-6, IL-10, TNF- !, and cortisol.
2. A 2 X 2 model used to assess PRE to POST exercise response to the OGTT, including Si.
3. Dependant t-tests comparing IL-6, IL-10, TNF- !, and cortisol for both SIT sessions.
4. Dependant t-tests comparing change in Si following SIT sessions at baseline and 24 hr.
5. Pearson’s correlation coefficients will be calculated to examine the relationships between Si and changes in myokine
response.
XII. DATA AND SAFETY MONITORING
• If the research involves greater than minimal risk and there is no provision made for data and safety monitoring
by any sponsor, include a data and safety-monitoring plan that is suitable for the level of risk to be faced by
subjects and the nature of the research involved.
• If the research involves greater than minimal risk, and there is a provision made for data and safety monitoring
by any sponsor, describe the sponsor’s plan.
• If you are serving as a Sponsor-Investigator, identify the Contract Research Organization (CRO) that you will be
using and describe the provisions made for data and safety monitoring by the CRO. Guidance on additional
requirements for Sponsor-Investigators is available at http://www.research.vcu.edu/irb/wpp/flash/X-2.htm
Exclusion criteria will be any person classified as Moderate or High risk for cardiovascular disease according to current
ACSM Guidelines for Exercise Testing and Prescription (ACSM, 8th ed, 2009), as well as those with a body fat above 25%
for men, and 32% for women, orthopedic limitations preventing full participation in the study, pre-diabetes or diabetes
mellitus (fasting glucose > 126), self-reported hypothyroidism, renal disease. In addition, women who are pregnant or
those suffering from premature menopause will also be excluded. Self-reported health history will also be reviewed, and
each potential subject will be asked to indicate whether he has used any prescription stimulant drugs in the past in the past
6 months. Furthermore, individuals will be asked to review the list of illegal drugs on the Health History Questionnaire
(Appendix C) and answer YES to having used any of the drugs listed or NO to never having used any of the drugs listed.
We will not ask them to indicate any specific drug use, nor will we record such use. A simple YES or NO will determine
eligibility for participation in this study.
All personnel are certified in CPR/BLS, and subjects will have heart rate, blood pressure measurements taken before and
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after exercise sessions, as well as rating of perceived exertion during exercise. Should an exercise session result in or
indicate an adverse outcome, the session will be terminated. Further, all sprints sessions will be conducted at the CRS.
Should any adverse event occur the safety protocols for the CRS will be followed. AED and ALS are available in the
CRS. We will defer specific protocols to those endorsed by the CRS to Lou Usry, RN, CCRP, CNML Senior
manager (804-828-9229). Should an adverse event occur, the test session will be terminated and the subject care will be
managed by CRS staff. All data collection will be tracked via our study event tracking form (Appendix E), including
adverse events. All adverse events will be reported to the IRB within 14 days of the occurrence. Finally, only listed study
personnel will have access to data. Both Dr. Acevedo and Mr. Harnish will have direct access to all forms of subject data,
and only Mr. Harnish will be involved in the consent process. In the event of medical questions for concerns, Dr. Richard
Kunz (VCU PM&R), a licensed physician, will assume the medical consulting role left vacated by Dr. Ericksen. Dr. Kunz
has been familiarized with the study protocol and can be reached at North 2, 804.828.0861.
Special Note: The Health History Questionnaires for those individuals who are excluded from the study following a review
of the inclusion and exclusion criteria will be immediately destroyed (shredded), while consent forms will be stored in a
separate secure “screen failure” for future reference.
XIII. MULTI-CENTER STUDIES
If VCU is the lead site in a multi-center project or the VCU PI is the lead investigator in a multi-center project,
describe the plan for management of information that may be relevant to the protection of subjects, such as reporting
of unexpected problems, project modifications, and interim results.
N/A

XIV. INVOLVEMENT OF NON-VCU INSTITUTIONS/SITES (DOMESTIC AND FOREIGN)
1. Provide the following information for each non-VCU institution/site (domestic and foreign) that has agreed to
participate (all non-VCU institutions/sites are to be listed, including those who obtain local IRB approval from
their own institution and those who request deferral to the VCU IRB):
• Name of institution/site
• Contact information for institution/site
• Engaged in Research or not (if YES AND the research involves a DIRECT FEDERAL AWARD made to
VCU, include FWA #). See OHRP’s guidance on “Engagement of Institutions in Research” at
http://www.hhs.gov/ohrp/policy/engage08.html.
• Request for the VCU IRB to review on behalf of the Non-VCU institution? Submit either the template

•

Authorization Agreement or Individual Investigator Agreement with this application. See additional
requirements found at http://www.research.vcu.edu/irb/wpp/flash/XVII-6.htm.
See VCU WPPs:
http://www.research.vcu.edu/irb/wpp/flash/XVII-6.htm and
http://www.research.vcu.edu/irb/wpp/flash/XVII-11.htm.

Name of Institution

Contact Information for
Site

Engaged (Y/N)
and
FWA # if applicable

Request for VCU IRB to
review on behalf of the
non-VCU institution
(Y/N)*

*NOTE: If a Non-VCU site is engaged in the research, the site is obligated to obtain IRB review or request that the VCU
IRB review on its behalf.
2. Provide a description of each institution’s role (whether engaged or not) in the research, adequacy of the facility
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(in order to ensure participant safety in the case of an unanticipated emergency), responsibilities of its
agents/employees, and oversight that you will be providing in order to ensure adequate and ongoing protection of the
human subjects. You should only identify institutions that have agreed to participate. If additional institutions agree
to participate at a later time, they must be added by amendment to the protocol.
N/A
XV. HUMAN SUBJECTS INSTRUCTIONS
ALL sections of the Human Subjects Instructions must be completed with the exception of the section entitled
“Special Consent Provisions.” Complete that section if applicable.
A. DESCRIPTION
Provide a detailed description of the proposed involvement of human subjects or their private identifiable data.
Prior to enrollment, subjects will complete a risk factor assessment and basic health history based on ACSM guidelines
and will ask about illegal drug use; the screening will allow us to identify any High risk individuals, or those otherwise
unfit to take part in the study. The history and screening (Appendices C and D, respectively) will be conducted by Mr.
Harnish in the form of a question and answer session; Mr. Harnish is a certified ACSM Health Fitness Specialist, while Dr.
Acevedo is a certified Clinical Exercise Specialist. No other health details will be taken or stored. Inclusion criteria will
include men between the ages of 18-35 years old who do not engage in regular physical activity more than two days per
week, but have a body fat of < 25%. Exclusion criteria will be any person classified as Moderate or High risk for
cardiovascular disease according to current ACSM clinical guidelines, as well as those with a body fat above 25% for men,
and 32% for women, orthopedic limitations preventing full participation in the study, pre-diabetes or diabetes mellitus
(fasting glucose > 126), self-reported hypothyroidism, renal disease. In addition, women who are pregnant or those
suffering from premature menopause will also be excluded. Chris Harnish will be responsible for determining eligibility of
each subject. Once consent forms are signed, they will be kept under lock and key, with risk assessments, in Mr. Harnish’s
office in 500 AC. Each consent form will be given a unique number. All further data collection will only use that number.
Each participant will be out-patient perform a series of blood samples (totaling approximately 160 ml, or 3/4 cup of
blood) and exercise sessions over 3 weeks. FOUR 2 hr oral glucose tolerance tests (OGTT) will be performed (five 5 ml
samples per test), plus blood sampling (~10 ml each) will be taken prior to, immediately following and 1 hr after exercise
sessions; cortisol will be measure during each PRE test sample (four for OGTT and two for sprints). Sprint sessions will
include two different acute sprint protocols – a Tabata – 10X 20 sec sprints/10 sec rest, or Wingate – 5X 30 sec sprints/240
sec rest, with each training bout separated by no less than one week. Each exercise visit will last approximately 30
minutes. Additional testing will include a maximal graded exercise test (see below), a body fat test, and each will be asked
to complete a 3 day diet recall. Body fat testing will use bioelectrical impedance (BIA), which is simple, fast and poses no
risk to the participant.
Following the first OGTT, subjects will perform a bicycle VO2 peak test conducted on an electronically braked bicycle
ergometer (VIA Sprint 150P, Viasys Healthcare, Yorba Linda, CA). VO2 and HR will be measured continuously using a
Parvo OneMax system (Parvo Medics, Salt Lake City, UT) and Polar HR monitor (Polar Electro Inc., New Success, NY),
respectively. Subjects will be instructed to pedal at their preferred cadence throughout testing. The initial workload will be
set at 100 W, increasing by 20 W every 2 min until volitional exhaustion is reached. Blood pressure will be measured with
a clinical mercury manometer in the final 30 sec of each stage. For all testing and exercise sessions, activity will be
terminated if HR should exceed 220 beats/min or BP exceeds 250 systolic and/or 115 mmHg diastolic blood pressure.
Other indications for test termination include a drop in systolic BP of > 10 mmHg, angina, dizziness, nausea or volitional
exhaustion (ACSM Guidelines for Exercise Testing and Prescription, 2008).
Table 1. Comparison of Tabata vs. Wingate protocols.
Workload
# of
Sprint
Recovery
Total Sprint
Sprints
Time
Time
Time
(% BM)
(Sec)
(Sec)
(Sec)
Tabata

5

10

20

10

200

Wingate

7

5

30

240

150
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B. SUBJECT POPULATION
Describe the subject population in terms of sex, race, ethnicity, age, etc., and your access to the population that will
allow recruitment of the necessary number of participants. Identify the criteria for inclusion or exclusion of all
targeted populations and include a justification for any exclusions. Explain the rationale for the involvement of
special cases of subjects, such as children, pregnant women, human fetuses, neonates, prisoners or others who are
likely to be vulnerable. If you plan to allow for the enrollment of Wards of the State (or any other agency, institution,
or entity), you must specifically request their inclusion and follow guidance in VCU IRB WPP XV-3: Wards and
Emancipated Minors available at http://www.research.vcu.edu/irb/wpp/flash/XV-3.htm.
One important note, however, is that extensive review of the literature revealed that power analyses from all but
the two listed studies yielded unverifiable estimates on pre and post differences, making calculations unreliable at
best. Therefore, drawing about our recent pilot study, we were able to measure cytokine response to a single Tabata
session. These data indicate an increase of at least 6 pg.mL-1 for IL-6 and IL-10, which indicates that a sample size of at
least 24 total subjects, or 12 per SIT group, would yield a power of at least 80%.
Participants
Up to 16 men and 16 women will be actively recruited from the VCU Monroe and MCV campuses using word of
mouth, flyers and emails (see appendix A). As outlined above, this sample size will yield a power of 90% or greater for all
dependent measures. All subjects will be evaluated for safe exercise participation using an ACSM risk factor assessment
(see appendix B-ACSM Guidelines for Exercise Testing and Prescription) and informed of the purposes of the study
before signing an informed consent document approved by the Virginia Commonwealth University IRB. Inclusion criteria
will include men between the ages of 18-35 years old who do not engage in regular physical activity more than two days
per week, but have a body fat of < 25%. Exclusion criteria will be any person classified as Moderate or High risk for
cardiovascular disease according to current ACSM clinical guidelines, as well as those with a body fat above 25 for men,
and 32% for women, orthopedic limitations preventing full participation in the study, pre-diabetes or diabetes mellitus
(fasting glucose > 126), self-reported hypothyroidism, renal disease. In addition, women suffering from premature
menopause will also be excluded.
We had chosen to study just males due to the reported differences between men and women in both cytokine levels
(Ives et al. 2011; O’Brien et al. 2007; Fernandez-Real et al. 2001) and metabolic parameters like insulin sensitivity (Ives et
al. 2011; Fernandez-Real et al. 2001; Clausen et al. 1996). However, since beginning recruitment we have had several
inquiries from women. We have also garnered additional resources to collect data on women, which will allow us to
greatly increase our sample size and directly compare gender differences.
C. RESEARCH MATERIAL
Identify the sources of research material obtained from individually identifiable living human subjects in the form of
specimens, records, or data. Indicate whether the material or data will be obtained specifically for research purposes
or whether use will be made of existing specimens, records, or data.
We will be collecting height, weight, age, risk factor assessment (as outlined above), exercise capacity and blood specific to
our research question.
D. RECRUITMENT PLAN
Describe in detail your plans for the recruitment of subjects including:
(1) how potential subjects will be identified (e.g., school personnel, health care professionals, etc),
(2) how you will get the names and contact information for potential subjects, and
(3) who will make initial contact with these individuals (if relevant) and how that contact will be done.
If you plan to involve special cases of subjects, such as children, pregnant women, human fetuses, neonates, prisoners
or others who are likely to be vulnerable, describe any special recruitment procedures for these populations.
We have developed a number of strategies relevant to all populations that mitigate these potential recruitment problems.
Potential subjects will be actively recruited via flyers (see Appendix A) on VCU campuses and around Richmond, scripted
class announcements (Appendix A), and word of mouth. We have also applied for two grant awards, which if awarded, will
provide _7/31/13
funds to compensate subjects. All subjects will also be provided with any health and fitness information collected,
Version:
and
advised
Page 8 of 14 on exercise changes they may make following the study.

Rev. Date: 9-1-12
IRB USE - Do Not Delete

class announcements (Appendix A), and word of mouth. We have also applied for two grant awards, which if awarded, will
provide funds to compensate subjects. All subjects will also be provided with any health and fitness information collected,
and advised on exercise changes they may make following the study.
E. PRIVACY OF PARTICIPANTS
NOTE: Privacy refers to individuals and their interests in controlling access to their identities, their physical person,
and how and what kind of information is obtained about them. Privacy also encompasses the interests of defined
communities (e.g. those with a certain diagnosis or social circumstance) in controlling access to the group identity and
information about the group or individuals as part of the group.
Describe how the privacy interests of subjects (and communities, if appropriate) will be protected including:
(1) in the research setting (e.g., in the identification, recruitment, and intervention settings) and
(2) with the information being sought and the way it is sought. For example, providing drapes or barriers,
interviewing in a private room, and collecting only the amount of sensitive information needed for identification,
recruitment, or the conduct of the study.
Individual participants need only complete a health history assessment and provide their name and date of birth at consent.
These identifiers will not be needed after the consent process and will remain locked at all times during and after the study.
Subjects will have a private space to complete all consent forms. Subjects will participate in testing and exercise in a private
lab with minimal access and suitable, private changing areas. Data collection will include age, body fat, exercise capacities,
and blood exercise response.
Participants will be given a unique numerical identifier written at the top of each consent. Once consent forms are collected
and processed, they will then be locked in a cabinet within Mr. Harnish’s office. All subsequent data collection will only use
the unique identifier.
F. CONFIDENTIALITY OF DATA
NOTE: Confidentiality refers to the way private, identifiable information about a subject or defined community is
maintained and shared.
Check all of the following precautions that will be used to maintain the confidentiality of identifiable information:
Paper-based records will be kept in secure location and only accessed by authorized study personnel
Electronic records will be made available only to those personnel in the study through the use of access controls and
encryption
Identifiers will be removed from study-related data (data is coded with a key stored in a separate secure location)
For research involving web-based surveys, data is secured via passwords and encryption
Audio or video recordings of subjects will be transcribed and then destroyed to prevent audio or visual identification.
Note the date of destruction (e.g., 3 months from close of study; after transcription is determined to be error free).
Obtaining a Certificate of Confidentiality
Other precautions:
Subjects will have private space to complete all consent forms.

G. POTENTIAL RISKS
Describe potential risks (physical, psychological, social, legal, or other) and assess their likelihood and seriousness.
Where appropriate, describe alternative treatments and procedures that might be advantageous to the subjects.
What may present a risk?

Possible Risk/Side Effect

How often has it occurred?

Venous catheter insertion

1. Localized swelling, soreness, bruising, and
chance of infection, bleeding, pain,
lightheadedness or possible fainting.

1. It occasionally occurs
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Venous catheter insertion
and Blood draws

1. Localized swelling, soreness, bruising, and
chance of infection, bleeding, pain,
lightheadedness or possible fainting.

1. It occasionally occurs

Samples from the earlobe

2.Soreness, bruising, infection, and scarring.
A total of one large drop of blood will be taken
each time
1. Light-headedness, shortness of breath and
altered heart rate & blood pressure. Muscle
soreness at your neck, upper back, shoulders,
arms & hands
2. Fainting, heart attacks or death

2. It occasionally occurs

2. It is very rare

3. Muscle soreness

3. It is fairly common

1. Nausea from drinking a lot of glucose (sugar)

1. Occasionally occurs

Exercise Testing/Sessions

Oral Glucose Tolerance
Test

1. It is fairly common

H. RISK REDUCTION
Describe procedures for protecting against or minimizing potential risk. Where appropriate, discuss provisions for
ensuring necessary medical or professional intervention in the event of adverse events to the subjects. Describe the
provisions for monitoring the data collected to ensure the safety of subjects, if any.
To minimize the risk of adverse events, only apparently healthy LOW RISK individuals fit for exercise will participate in
this study; no matter how thorough the screening process, it is impossible to define anyone as “healthy”, therefore the
ACSM uses the term apparently, or outwardly healthy, with no specific signs of disease. It is not necessary to have a
physician present during exercise testing with Low Risk individuals. A self-report Health History Questionnaire will be
reviewed, and each potential subject will be asked to indicate whether they have used any prescription stimulant drugs in
the past in the past 6 months. Furthermore, individuals will be asked to review the list of illegal drugs on the Health
History Questionnaire (Appendix C) and simply answer YES to having used any of the drugs listed or NO to never having
used any of the drugs listed. All subjects will be advised of the risk for arrhythmias and death after using strong stimulants
like amphetamines and cocaine.
Heart rate and effort level will be monitored throughout all exercise sessions. Individuals exhibiting abnormally high heart
rates or blood pressures, or symptoms of nausea or syncope, will be stopped from further exercise and asked to lie down
for further monitoring. In the event of emergencies, emergency help will be contacted based on CRS standard operating
procedures. All research staff are trained in CPR/BLS or ALS and safety procedures will be reviewed prior to beginning
the study. An AED will be available should the need arise and emergency numbers will be available to all personnel.
I. ADDITIONAL SAFEGUARDS FOR VULNERABLE PARTICIPANTS
Describe any additional safeguards to protect the rights and welfare of participants if you plan to involve special cases
of subjects such as children, pregnant women, human fetuses, neonates, prisoners or others who are likely to be
vulnerable.
Safeguards to protect the rights and welfare of participants might relate to Inclusion/Exclusion Criteria: (“Adults
with moderate to severe cognitive impairment will be excluded.” “Children must have diabetes. No normal controls
who are children will be used.”) Consent: (“Participants must have an adult care giver who agrees to the participant
taking part in the research and will make sure the participant complies with research procedures.” “Adults must be
able to assent. Any dissent by the participant will end the research procedures.”) Benefit: (“Individuals who have not
shown benefit to this type of drug in the past will be excluded.”).
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N/A
J. RISK/BENEFIT
Discuss why the risks to participants are reasonable in relation to the anticipated benefits to subjects and in relation
to the importance of the knowledge that may reasonably be expected to result. If a test article (investigational new
drug, device, or biologic) is involved, name the test article and supply the FDA approval letter.
None of the study procedures performed in this study exceed what would occur in routine medical testing. Blood sampling
will involve small samples, and subjects will be performing exercise sessions at an intensity level that are not uncommon
for individuals in this range during general recreation on the weekends (e.g., football, basketball pick up games, or general
“play”). While individual benefits will be unlikely, this research will provide greater insight into the underlying
mechanisms for why sprint exercise improves metabolic function, as has been shown in many different populations.
Further, understanding the cytokine/myokine response to brief exercise may allow us to develop more optimal training
programs to treat metabolic diseases, like diabetes, with exercise.
K. COMPENSATION PLAN
Compensation for participants (if applicable) should be described, including possible total compensation, pro-rating,
any proposed bonus, and any proposed reductions or penalties for not completing the project.
No compensation will be provided for completing this study. However, participants will receive a summary of their health
screening, fitness test results and consultation on starting an exercise program.

L. CONSENT ISSUES
1. CONSENT PROCESS
Indicate who will be asked to provide consent/assent, who will obtain consent/assent, what language (e.g., English,
Spanish) will be used by those obtaining consent/assent, where and when will consent/assent be obtained, what steps
will be taken to minimize the possibility of coercion or undue influence, and how much time will subjects be afforded
to make a decision to participate.
All health screening and consents will be conducted in English by Chris Harnish at the HHP lab in Franklin Street Gym
room 332. All subjects informed of the purposes of the study verbally before signing an informed consent document
approved by the Virginia Commonwealth University IRB. Once consent has been obtained, we will complete a full health
history (as outlined above) and risk factor assessments will use a checklist (Appendix C). Interested participants may take
the consent home to read and will be afforded as much as is feasible to conduct the study.

2. SPECIAL CONSENT PROVISIONS
If some or all subjects will be cognitively impaired, or have language/hearing difficulties, describe how capacity for
consent will be determined. Consider using the VCU Informed Consent Evaluation Instrument available at
http://www.research.vcu.edu/irb/guidance.htm. If you anticipate the need to obtain informed consent from legally
authorized representatives (LARs), please describe how you will identify an appropriate representative and ensure
that their consent is obtained. Guidance on LAR is available at http://www.research.vcu.edu/irb/wpp/flash/XI-3.htm.
N/A
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3. ASSENT PROCESS
If applicable, explain the Assent Process for children or decisionally impaired subjects. Describe the procedures, if
any, for re-consenting children upon attainment of adulthood. Describe procedures, if any, for consenting subjects
who are no longer decisionally impaired. Guidance is available at http://www.research.vcu.edu/irb/wpp/flash/XV2.htm and http://www.research.vcu.edu/irb/wpp/flash/XVII-7.htm.
N/A
4. REQUESTS FOR WAIVERS OF CONSENT (COMPLETE IF REQUESTING ANY TYPE OF WAIVER OF CONSENT OR ASSENT)
4-A. REQUEST TO WAIVE SOME OR ALL ELEMENTS OF INFORMED CONSENT FROM SUBJECTS OR PERMISSION FROM
PARENTS: A waiver of informed consent means that the IRB is not requiring the investigator to obtain informed consent OR
the IRB approves a consent form that does not include or alters some/all of the required elements of consent. Guidance is
available at http://www.research.vcu.edu/irb/wpp/flash/XI-1.htm. NOTE: Waiver is not allowed for FDA-regulated
research unless it meets FDA requirements for Waiver of Consent for Emergency Research (see below).
4-A.1. Explain why a waiver or alteration of informed consent is being requested.
4-A.2. Describe how this study meets ALL FOUR of the following conditions for a waiver or alteration:
• The research involves no more than minimal risk to the participants. ! Explain how your study meets this
criteria:
•

The waiver or alteration will not adversely affect the rights and welfare of participants. ! Explain how your
study meets this criteria:

•

The research could not practicably be carried out without the waiver or alteration. ! Explain how your study
meets this criteria:

•

Will participants be provided with additional pertinent information after participation?
Yes
No ! Explain why not:

4-B. REQUEST TO WAIVE DOCUMENTATION OF CONSENT: A waiver of documentation occurs when the consent process
occurs but participants are not required to sign the consent form. Guidance is available at
http://www.research.vcu.edu/irb/wpp/flash/XI-2.htm . One of the following two conditions must be met to allow for
consenting without signed documentation. Choose which condition is applicable and explain why (explanation
required):
The only record linking the participant and the research would be the informed consent form. The principal risk to the
participant is the potential harm resulting from a breach of confidentiality. Each participant will be asked whether he/she
wants documentation linking the participant with the research and the participants wishes will govern. ! Explain how
your study fits into the category:
The research presents no more than minimal risk of harm to participants & involves no procedures for which signed
consent is normally required outside of the research context. ! Explain how your study fits into the category:
4-C. REQUEST TO WAIVE SOME OR ALL ELEMENTS OF ASSENT FROM CHILDREN ! AGE 7 OR FROM DECISIONALLY
IMPAIRED INDIVIDUALS: A waiver of assent means that the IRB is not requiring the investigator to obtain assent OR
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the IRB approves an assent form that does not include some/all of the required elements. Guidance is available at
http://www.research.vcu.edu/irb/wpp/flash/XV-2.htm.
4-C.1. Explain why a waiver or alteration of informed consent is being requested.
In order for the IRB to approve a request for waiver of assent, the conditions for 4-C.2, 4-C.3, OR 4-C.4 must be met.
Check which ONE applies and explain all required justifications.
4-C.2.

Some or all of the individuals age 7 or higher will not be capable of providing assent based on their
developmental status or impact of illness. ! Explain how your study meets this criteria:

4-C.3.

The research holds out a prospect of direct benefit not available outside of the research. ! Explain how
your study meets this criteria:

4-C.4.
Describe how this study meets ALL FOUR of the following conditions:
• The research involves no more than minimal risk to the participants. ! Explain how your study meets this criteria:

•

The waiver or alteration will not adversely affect the rights and welfare of participants. ! Explain how your study
meets this criteria:

•

The research could not practicably be carried out without the waiver or alteration. ! Explain how your study meets
this criteria:

•

Will participants be provided with additional pertinent information after participation?
Yes
No ! Explain why not:

4-D. REQUEST TO WAIVE CONSENT FOR EMERGENCY RESEARCH: Describe how the study meets the criteria for
emergency research and the process for obtaining LAR consent is appropriate. See guidance at
http://www.research.vcu.edu/irb/wpp/flash/XVII-16.htm.
N/A
5. GENETIC TESTING
If applicable, address the following issues related to Genetic Testing.
5-A. FUTURE CONTACT CONCERNING FURTHER GENETIC TESTING RESEARCH
Describe the circumstances under which the subject might be contacted in the future concerning further participation
in this or related genetic testing research.
N/A
5-B. FUTURE CONTACT CONCERNING GENETIC TESTING RESULTS
If planned or possible future genetic testing results are unlikely to have clinical implications, then a statement that the
results will not be made available to subjects may be appropriate. If results might be of clinical significance, then
describe the circumstances and procedures by which subjects would receive results. Describe how subjects might
access genetic counseling for assistance in understanding the implications of genetic testing results, and whether this
might involve costs to subjects. Investigators should be aware that federal regulations, in general, require that testing
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results used in clinical management must have been obtained in a CLIA-certified laboratory.
N/A
5-C. WITHDRAWAL OF GENETIC TESTING CONSENT
Describe whether and how subjects might, in the future, request to have test results and/or samples withdrawn in
order to prevent further analysis, reporting, and/or testing.
N/A
5-D. GENETIC TESTING INVOLVING CHILDREN OR DECISIONALLY IMPAIRED PARTICIPANTS
Describe procedures, if any, for consenting children upon the attainment of adulthood. Describe procedures, if any,
for consenting participants who are no longer decisionally impaired.
N/A
5-E. CONFIDENTIALITY OF GENETIC INFORMATION
Describe the extent to which genetic testing results will remain confidential and special precautions, if any, to protect
confidentiality.
N/A
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Summary of Progress for IRB # 14990
The study titled, Comparison of two different work to rest ratios on the acute metabolic and
inflammatory effects of a single bout of sprint interval training, has been progressing well since
September of 2013. To date we have enrolled 17 subjects, with a total of 15 completing testing as
February 19th; our final subject completed testing on the 19th, with no further enrollees. The data
collection for the study is complete. The following is a summary of subject data:

Consent:

17

Completed:

15 (13 males, 2 females)

Currently enrolled:

0 (all collection completed)

Withdrawals:

2 (1 male, 1 female)*

Unanticipated events:

7 (Nausea)**

Adverse events:

0

* Withdrawals: One male subject developed bronchitis following the first baseline OGTT and
withdrew. One female withdrew prior to any study appointments due to lack of time.
** See below.
At the end of August, Jeffrey Erickson, medically responsible consultant, left VCU for a
new position. Dr. Elizabeth Ripley temporarily filled in as our medical consultant for a brief
period before Dr. Richard Kunz assumed the role August 16th, 2013.
In October we received approval to begin enrolling women (see amendment below) into
the study and have presently completed a total of 2. We also have 2 males currently enrolled in
the study, and expect to complete their appointments by mid-January. All but one subject have
been recruited from the VCU Monroe or MCV campus and have generally tolerated the research
well. We have completed all testing at this time. No further subjects have been enrolled
since testing ended in February.

June 2nd, 2014

Summary of Progress for IRB # 14990
Amendments:
Only one amendment was added to the study, the request to enroll women. Approval received
10/23/13.
Unanticipated Events:
While we have advised subjects on the potential for dizziness and nausea during sprint training,
we did not anticipate the prevalence (7 of 15; 6 males, 1 female) of nausea during our Wingate
sprint sessions. This is not uncommon, but generally not seen as often in either research or
classroom settings. We surmise the greater prevalence is due to subjects exercising in a fasted
state. However, no adverse outcomes have occurred, and all subjects have reported recovering
quickly after or even during exercise. It has not had a significant impact on data collection.
Additional Funding:
In order to fund the additional analysis of cytokines for this study we established a crowd
funding project page through Experiment.com, the leading research crowd funding
platform. The page provides an abridged layperson summary of the study purposes and
methodology, and adheres to the submitted IRB research plan (6.3.14). Individual donors
are known to the public, and those with potential conflicts of interest, like research
subjects, can be declined (no persons with COI’s donated). Expenditures for study
expenses are documented and must conform with the outline of the study on the website.
Crowd funding goals must be met for any funds to be made available. Our project
successfully met our goal and we will be rerunning some blood samples to complete all our
analyses.

June 2nd, 2014
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Would you like to test your fitness level?
Do you want to learn more about your Health?
If you answered yes to any of these questions, are between the
ages of 18 and 35 years, and do not participate in strenuous
exercise training, you may be invited to participate in a 3 week
study examining the effect of sprint exercise and health
improvement. During this time you will only participate in TWO
sprint sessions lasting ~30 minutes and a few other non-exercise
test sessions on the VCU campus, including blood draws. As part
of your participation you will receive:
•
•
•
•

A FREE cardiovascular fitness test
A FREE dietary assessment
A FREE Body Fat test
Detailed information on your cardiovascular fitness and advice
on exercise training

Research will involve a series of tests over a 3 week period of time
at no cost to you. If you would like more information, please contact
Chris Harnish, M.S. in the Dept of Health and Human Performance
at VCU.
Sprint Study
harnishc@vcu.edu
804.828.1948
Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Sprint Study
harnishc@vcu.edu
804.828.1948

Version 2; 7/31/13

EMAIL ANNOUNCEMENT

Would you like to test your fitness level?
Do you want to learn more about your Health?
If you answered yes to any of these questions, are between the ages of 18
and 35 years, and do not participate in strenuous exercise training, you may
be invited to participate in a 3 week study examining the effect of sprint
exercise and health improvement. During this time you will only participate
in TWO sprint sessions lasting ~30 minutes and a few other non-exercise
test sessions on the VCU campus including blood draws. As part of your
participation you will receive:
• A FREE cardiovascular fitness test
• A FREE dietary assessment
• A FREE Body Fat test
• Detailed information on your cardiovascular fitness and advice on
exercise training
Research will involve a series of tests over about a 3 week period of time at
no cost to you. If you would like more information, please contact Chris
Harnish, M.S. in the Dept of Health and Human Performance at VCU.
Please contact Chris Harnish @ harnishc@vcu.edu
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CLASS ANNOUNCEMENTS
We are conducting a three week trial comparing two different sprint interval
sessions. We want to understand the effect of sprint exercise on health
improvements. During the study you will only participate in TWO sprint
sessions lasting ~30 minutes and a few other non-exercise test sessions on
the VCU campus including blood draws. As part of your participation you
will receive:
• A FREE cardiovascular fitness test
• A FREE dietary assessment
• A FREE Body Fat test
• Detailed information on your cardiovascular fitness and advice on
exercise training
Research will involve a series of tests over a 3 week period of time at no
cost to you. If you would like more information, please contact Chris
Harnish, M.S. in the Dept of Health and Human Performance at VCU.
Contact information can be obtained from myself or your instructor.
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RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM
TITLE: Comparison of two different work to rest ratios on the acute metabolic and
inflammatory effects of a single bout of sprint interval training
VCU IRB PROTOCOL NUMBER: HM14990
INVESTIGATOR: Edmund Acevedo
If any information contained in this consent form is not clear, please ask the study doctor
or the study staff to explain any information that you do not fully understand. You may
take home an unsigned copy of this consent form to think about or discuss with family or
friends before making your decision.
PURPOSE OF THE STUDY
The purpose of this research study is to compare the health benefits of using two different
types of sprint exercise with long and short rest periods. You are being asked to take part
in this study because you have the age and body characteristics that are representative of
common research subjects.
DESCRIPTION OF THE STUDY
Sprint exercise involves pedaling a bicycle as fast as possible for 30 sec or less using a
resistance setting based on your body weight. You will be required to perform an exercise
fitness test and a series of blood tests over a one week period of time followed by two
individual sprint sessions, one with short rest and one with long rests, along with some
blood tests after each sprint session. Each session will be separated by at least one week
and your total time commitment for the study will be three weeks. Women who are
pregnant or experiencing premature menopause will not be included in this study.
Significant new findings developed during the course of the research like improvement in
how you process sugar and improvement in blood chemicals that block sugar processing
may allow us to better use exercise to control diseases like diabetes. Approximately 16
men and 16 women will participate in this study.
PROCEDURES
If you decide to be in this research study, you will be asked to sign this consent form after
you have had all your questions answered. Remaining procedures will take place on the
MCV campus’ Clinical Research Service in the North Hospital.
At your first study visit (Day 1) of about 1 hour, your medical history will be taken and
your risk for heart related disease will be assessed to ensure it is safe for you to
participate in this study. Other measurements will include your height and weight, pulse,
[Version # 10/03/13]
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and blood pressure. You will also be given a 3 day dietary recall packet for you to record
what you eat prior to the next visit.
On your second visit (~about 3 days later) you will perform an oral glucose tolerance test,
or OGTT, after an overnight fast between 7 and 8 am; an overnight fast means that you
may not eat any food or drink any beverage, other than water, after 8 pm the night prior
to any exercise session and/or blood testing. It is also important that you do not take any
stimulant products containing caffeine, guarine (guarana), taurine, or nicotine, as well as
pain relievers, like aspirin, acetaminophen, naproxen sodium, or ibuprofen, during this
fasting period. Any of these products could adversely affect your response to sprint
exercise. An OGTT examines your sugar tolerance and how your body uses insulin. A
nurse will insert a catheter for blood sampling ease, and a blood sample (about 1-2
tablespoons each) will be taken to measure the amount of glucose and insulin, as well as
specific blood chemicals and hormones that affect glucose and insulin. You will then
drink a half cup of a sugar drink. Additional blood samples will be taken just prior to
drinking the sugar water and then 30, 60, 90 and 120 minutes after drinking. This test will
be performed four times during the study. During this OGTT we will estimate the amount
of body fat you have using bio-electrical impedance (BIA); the BIA sends a miniscule
electrical current that estimates body fat from the amount of water you have in your body.
Following this OGTT, you will perform an exercise test on a bike. A plastic nose plug
will be placed on your nose and you will breathe into a rubber mouthpiece so that your
breathing can be measured. You will be asked to pedal at a set speed throughout the test
session, while workload increases every 2 minutes. You will continue to exercise until
you can no longer maintain the speed set, you wish to stop due to volitional exhaustion
(you feel you cannot continue), you feel ill, like nausea, or if you experience chest pain.
At the end of the test a tiny drop of blood will be collected from your earlobe with a
small lancet (the same device a person with diabetes uses to prick the end of their finger
to test blood sugar) to measure your lactic acid levels. You might experience some
earlobe soreness after testing. Measuring lactic acid helps determine how hard you
worked and how much sugar you burn. During the last part of the exercise test, you will
be verbally encouraged to continue as long as possible. You will complete this test once
during the study.
On your third visit (~day 10) you will complete another OGTT after an overnight fast at
the same time of morning as your second visit. This will allow us to be sure there are no
changes in your blood tests when you are not exercising; in other words, we should not
see a change without sprint exercise. These two visits will last about 2 hours each.
Your fourth visit will take place the following morning (day 11) after an overnight fast at
the same time as your first OGTT. We will take one initial blood sample prior to your
exercise session measure blood chemicals and hormones, then you will complete an easy
10 min warm-up of light bicycling before completing one of the following sprint exercise
sessions (the order you complete these will be determined using a simple coin toss prior
to your starting the study):
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Sprint session with short rest:
Sprint as fast as possible for 20 sec, then resting for 10 sec. You will repeat this TEN
total times (5 min total time), or until you can no longer sprint due to fatigue.
Sprint session with long rest
Sprint as fast as possible for 30 sec, then rest for 4 minutes. You will repeat this for five
total times, which will take less than 30 min total.
Following each sprint session we will immediately take a blood sample for
chemicals/hormones and a blood lactic acid measurement from the ear. You will then sit
quietly for 1 hour after your training session before a final blood sample is taken that day.
You are asked to refrain from any strenuous activity throughout the entire study period.
Each sprint session will last about 2 hours.
You will return to the lab the following morning, at the same prescribed time, for your
fifth visit (day 12). You will complete another OGTT after an overnight fast at the same
time of morning as your second visit. This will allow us to determine if the sprint
exercise changed your sugar processing ability or blood chemical levels. This visit will
take about 2 hours.
You will be given at least one full week of rest after this first sprint session.
Your sixth visit will then take place on day 20 after an overnight fast at the same time as
your first OGTT. We will take one initial blood sample prior to your final exercise
session to measure blood chemicals and hormones, you will then complete an easy 10
min warm-up of light bicycling before completing the other sprint exercise session. You
will again sit quietly for 1 hour after your training session before a final blood sample is
taken that day.
On your seventh and final visit (day 21), you will complete a final OGTT after an
overnight fast at the same time of morning as your second visit. This will allow us to
determine if the sprint exercise changed your sugar processing ability or blood chemical
levels and compare it to the other sprint exercise values.
Summary of Testing
Time
Day 0
Day 3 – 8 am
Day 10 – 8 am
Day 11 – 8 am
Day 12 – 8 am
Day 20 – 8 am
Day 21 – 8 am
[Version # 10/03/13]

Test Procedures that will be done
Consent forms signed and Health screening
OGTT 1, Body Fat Test, Bike fitness test
OGTT 2
Sprint Session 1
OGTT 3
Sprint Session 2
OGTT 4
Page 3 of 7

Time to Finish
~1 hr
~2 ! hrs
~2 hrs
~1 ! hrs
~2 hrs
~1 ! hrs
~2 hrs
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RISKS AND DISCOMFORTS
What may present a
risk?

Possible Risk/Side Effect

How
often
occurred?

Venous
catheter
insertion
and Blood draws

1. Localized swelling, soreness, bruising, and
chance of infection, bleeding, pain,
lightheadedness or possible fainting.

1. It occasionally occurs

Samples from the
earlobe

2.Soreness, bruising, infection, and scarring.
2. It occasionally occurs
A total of one large drop of blood will be
taken each time
1. Light-headedness, shortness of breath and 1. It is fairly common
altered heart rate & blood pressure.
Muscle soreness at your neck, upper back,
shoulders, arms & hands
2. Fainting, heart attacks or death
2. It is very rare

Exercise
Testing/Sessions

3. Muscle soreness
Oral
Glucose
Tolerance Test

has

3. It is fairly uncommon

1. Nausea from drinking a lot of glucose 1. Occasionally occurs
(sugar)

BENEFITS TO YOU AND OTHERS
There is no guarantee that you will receive any medical benefits from being in this study.
The information gained from this research study may lead to a better use of exercise in
management of diseases like diabetes and heart disease.
COSTS
There is no cost for the study visits.
PAYMENT FOR PARTICIPATION
Your participation is voluntary and you will not be paid to participate. However, you will
receive a summary of your health screening, fitness test results and consultation on
starting an exercise program.
ALTERNATIVE TREATMENT
Your alternative is not to participate in this study.
CONFIDENTIALITY
You should know that research data about you may be reviewed or copied by the sponsor
of the research or by Virginia Commonwealth University. Personal information about
you might be shared with or copied by authorized officials of the Department of Health
and Human Services. Potentially identifiable information about you will consist of
physical fitness, body fat, and overall health risk factors, as well as blood samples. Data
is being collected only for research purposes. Once your consent form is completed you
will receive a unique number ID for all study documents. Identification will then be
[Version # 10/03/13]
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stored in a secure location. Your name or other personal information will not appear in
any data collection or study documents. All personal identifying information will be kept
in password protected files and these files will be deleted within 3 years of completion.
Deidentified data will be kept indefinitely. Access to all data will be limited to study
personnel. A data and safety monitoring plan is established.
Although results of this research may be presented at meetings or in publications,
identifiable personal information pertaining to participants will not be disclosed.
COMPENSATION FOR INJURY or ILLNESS
If you are injured by, or become ill, from participating in this study, please contact your
study doctor immediately. Medical treatment is available at the Virginia Commonwealth
University Health System (VCU Health System). Your study doctor will arrange for
short-term emergency care at the VCU Health System or for a referral if it is needed.
Fees for such treatment may be billed to you or to appropriate third party insurance.
Your health insurance company may or may not pay for treatment of injuries or illness as
a result of your participation in this study.
To help avoid research-related injury or illness it is very important to follow all study
directions.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
Your participation in this study is voluntary. You may decide to not participate in this
study. Your decision not to take part will involve no penalty or loss of benefits to which
you are otherwise entitled. If you do participate, you may freely withdraw from the study
at any time. Your decision to withdraw will involve no penalty or loss of benefits to
which you are otherwise entitled.
Your participation in this study may be stopped at any time by the medical staff or
investigator without your consent. The reasons might include:
• the study doctor thinks it necessary for your health or safety;
• you have not followed study instructions; or
• administrative reasons require your withdrawal.
It is important to the study team if you are considering stopping so any risks can be
evaluated by the study personnel. If you leave the study before the final regularly
scheduled visit we ask you please contact us via telephone, email or in person.
QUESTIONS
If you have any questions, complaints, or concerns about your participation in this
research, contact:
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Edmund Acevedo, Principal Investigator
P.O. Box 842020
Dept of Health and Human Performance
Virginia Commonwealth University
Richmond, VA 23284
(804) 828-1948
eoacevedo@vcu.edu
and/or
Chris Harnish, student investigator
(804) 592-0512
harnishc@vcu.edu
The researcher/study staff named above is the best person(s) to call for questions about
your participation in this study.
If you have general questions about your rights as a participant in this or any other
research, you may contact:
Office of Research
Virginia Commonwealth University
800 East Leigh Street, Suite 3000
P.O. Box 980568
Richmond, VA 23298
Telephone: (804) 827-2157
Contact this number for general questions, concerns, or complaints about research. You
may also call this number if you cannot reach the research team or if you wish to talk to
someone else. General information about participation in research studies can also be
found at http://www.research.vcu.edu/irb/volunteers.htm.
Do not sign this consent form unless you have had a chance to ask questions and have
received satisfactory answers to all of your questions.
CONSENT
I have been provided with an opportunity to read this consent form carefully. All of the
questions that I wish to raise concerning this study have been answered.
By signing this consent form, I have not waived any of the legal rights or benefits, to
which I otherwise would be entitled. My signature indicates that I freely consent to
participate in this research study. I will receive a copy of the consent form once I have
agreed to participate.

[Version # 10/03/13]
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________________________________________________
Participant Name, printed
________________________________________________ ________________
Participant Signature
Date
________________________________________________
Name of Person Conducting Informed Consent
Discussion / Witness 3
(Printed)
________________________________________________ ________________
Signature of Person Conducting Informed Consent
Date
Discussion / Witness
________________________________________________ ________________
Principal Investigator Signature (if different from above)
Date 4
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VITA
Chris Harnish was born on May 12, 1974, in Amsterdam, New York, and is an American citizen.
Growing up in the central leather stocking region and later the key manufacturing site for
Cabbage Patch Kids, he graduated from Amsterdam High School in 1992. He went on to receive
a Bachelor of Science in Clinical Exercise Science from Ithaca College, in Ithaca, New York in
1996, and then attended the University of South Carolina, receiving a Masters of Science in
Exercise Physiology in 1999. He then spent three years teaching at Ithaca College before moving
to Cape Cod to work as a professional cycling coach and event promoter. He enrolled in the PhD
program at Virginia Commonwealth University in 2008.

